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Hepatic steatosis (fatty liver) is increasingly prevalent in the US, and is characterized by 
triglyceride accumulation within hepatocytes.  This is a direct result of an imbalance between 
lipid import, export, de novo lipogenesis, and beta oxidation.  Hepatic steatosis can also progress 
to nonalcoholic steatohepatitis (NASH) which is characterized by increased hepatocyte damage, 
inflammation, and fibrosis.  Further progression can lead to liver failure or hepatocellular 
carcinoma, requiring liver transplant or causing death.  Our lab recently created Mllt3 
conditional whole body knockout mice. These mice developed hepatic steatosis and NASH 
following Mllt3 deletion.  MLLT3 is a master gene regulator that is part of different chromatin 
remodeling complexes involved in activating or repressing gene expression. MLLT3 also 
contains a YEATS domain histone acylation reader with a preference for crotonylated histone 
tails.  Crotonylation post-translational modifications are found within promoters and enhancers 
of active genes.  Thus, MLLT3 functions in epigenetic gene regulation.   
We hypothesized that MLLT3 plays critical roles in maintaining liver lipid homeostasis 
by regulating expression of specific genes related to the generation of lipid species through its 
YEATS domain as well as through its function within specific chromatin modulating complexes.  
In order to determine the liver-intrinsic role of MLLT3 in hepatic steatosis, I used both in vitro 
and in vivo models. I knocked down MLLT3 in the HepG2 and Huh7 human hepatocellular 
carcinoma cell lines. This resulted in rapid accumulation of lipids which suggests a cell-intrinsic 





hepatocyte-specific Mllt3 deletion mice that our lab generated. Results from both model systems 
indicate that several genes which regulate different metabolic pathways, including de novo 
lipogenesis, are affected upon MLLT3/Mllt3 knockdown/knockout. Further study may define 

































MLLT3 History and Protein Structure 
 MLLT3, first identified in Mixed Lineage Leukemia as a chromosomal translocation 
partner for the MLL gene, is a chromatin reader protein which binds post translationally 
modified histone tails through its YEATS domain (Figure 1)1-3.  The MLLT3 chromatin reader 
domain is called the YEATS domain which is named after the first five proteins that were 
discovered to contain this type of structural domain (Yaf9, ENL, AF9, Taf14, and Sas5)4,5.  The 
structure of the YEATS domain is folded into an eight stranded immunoglobulin fold and binds 
to histone tail lysine modifications with its aromatic cage lined with serines6.  Initial chromatin 
binding assays showed that the YEATS domain had high affinity when binding to acetylated 
histone tails, similar to a bromodomain6.  More recently, however, it was shown to bind with 
higher affinity to crotonylated lysine histone tails (Kcr), thereby distinguishing it from classical 
bromodomain function3.  A crotonyl molecular structure is a three carbon short chain unsaturated 
carboxylic acid, making it one carbon longer then the classical acetylation post-translational 
modification.  Recent structural studies have shed insights to the structure of the YEATS domain 
in the ability to bind both acetylation and crotonylation.  Unlike a bromodomain, characterized 
by a wall inside of the aromatic cage, thereby restricting the length of a molecule it can bind, the
YEATS domain structure removes this blockade inside the binding pocket, essentially extending
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the size of the aromatic cage, thereby allowing it the ability to bind to longer carbon structures7.  
In addition to preferential binding to histone crotonylation, the YEATS domain has also been 
shown to bind to other post translational modifications such as propionylation and butyrylation3. 
However, the MLLT3 YEATS domain has the highest affinity for the crotonyl modification. 
Histone crotonylation is evolutionarily conserved from mouse to humans and is a marker for 
active promoters and primed enhancers8 .  Therefore, MLLT3 YEATS domain binding can mark 
chromatin regions with active transcription3.  Furthermore, histone acylation is dependent upon 
the metabolic state of the cell.  Since histone acetyl transferases such as CBP/p300 can catalyze 
both acetylation and crotonylation, competition for binding exists between Acetyl-CoA and 
Crotonyl-CoA9.   It has been shown that growing cells in low glucose will deplete the 
concentrations of acetyl-CoA essentially removing the competition for binding for acyl-CoAs 
such as Crotonyl-CoA9 . 
 In addition to the chromatin binding function of MLLT3, several labs, including ours, 
have shown the C-terminal domain of MLLT3 to actively play roles in binding four different 
gene regulatory complexes (Figure 1)10-12 .  Two of these complexes participate in gene 
activation, while the other two participate in gene repression.  The most well-known of these 
complexes is the Super Elongation Complex (SEC).  SEC is a multiprotein complex containing 
proteins such as RNA Polymerase II, AFF4, and pTEFb, which is involved in releasing paused 
RNA Polymerase II following pTEFb-dependent phosphorylation of RNA Polymerase II.  It has 
been reported that MLLT3 recruits the SEC complex, via direct interactions with AFF4, which in 
turn promote RNA Polymerase II to transcribe genes stuck at the transcriptional elongation 
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Figure 1. Schematic of MLLT3 Protein Structure. MLLT3 protein structure has the YEATS 
domain on the N-terminus with a CTD which binding to various protein complexes at the C-
Terminus. 
 
Moreover, this pause and release of RNA Polymerase II has been shown to be a rate-limiting 
step for transcription in mammalian cells and releasing RNA Polymerase II is dependent upon 
this recruitment13.  pTEFb is also recruited with the SEC and this protein is responsible for 
phosphorylating the carboxyl-terminal domain (CTD) of RNA Polymerase II on serine 2, as well 
as phosphorylation of both negative regulators NELF and DSIF, which in turn release one factor 
and modulate the other into a positive regulator of transcription14,15 .  These phosphorylation 
events release RNA Polymerase II from promoter pausing, which allows successful transcription 
of the gene14,15 .  The other activating complex that MLLT3 has a functional role within is with 
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DOT1L.  DOT1L, is a methytransferase which is responsible for histone H3 methylation at 
lysine 79 (H3K79).  This post translational modification has been shown to be a marker of active 
transcription16 .  One of the repressive complexes that MLLT3 binds is the canonical Polycomb 
Repressive Complex 1 (PRC1).  The interaction of MLLT3 with this complex is facilitated 
through direct interactions with CBX817,18 .  Finally, MLLT3 can also participate in a non-
canonical repressive Polycomb Complex through its direct interaction with BCOR19,20 .   
Interestingly, it has been shown, that binding of AFF4, DOT1L, CBX8, or BCOR to the MLLT3 
CTD, which occurs in a mutually exclusive manner, occurs before assimilation of the remainder 
of proteins that are involved in those respective complexes.21  
Liver Metabolism 
 The liver is the main organ for metabolic processing and is responsible for maintaining 
homeostasis through the cooperation of many proteins and enzymes that maintain the balance 
between glucose, lipid, steroid, and cholesterol synthesis, degradation, and storage (Figure 2).  
Briefly, after food is digested by the intestines, various metabolites, including glucose, fatty 
acids, and amino acids are absorbed and transferred to the liver via the portal vein22 .  The fate of 
these molecules depends on functionality of the liver.  Following eating, glucose is both 
converted into glycogen for storage and into fatty acids and other metabolic intermediates22 .  
Fatty acids, esterified with glycerol-3-phosphate, are converted into triglycerides (TAGs)  
which are then stored in lipid droplets.  These triglycerides can also be transferred out of the liver 
via very-low-density-lipoproteins, which provide TAGs for other parts of the body22.  The liver 
also plays critical roles under fasting or starvation conditions.  During this time, the liver releases 
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TAGs and glucose into the circulation where it is utilized by various tissues22 .  During oxygen 
deprivation, muscle and cardiac tissues release metabolic intermediates that can be utilized by 
the liver to make glucose through gluconeogenesis22.  The liver can also break down 
triglycerides by beta oxidation, and use them for ketone body formation which can then be sent 
to different tissues, such as the brain and heart22.  Pathways in liver metabolism involve 
gluconeogenesis, glycolysis, TCA cycle, de novo lipogenesis, and beta oxidation.  Briefly, 
glycolysis involves importing glucose, during the fed state, into the cells and catabolizing it 
through multiple enzymatic reactions, into pyruvate22.   Subsequently, pyruvate can be shuffled 
into The Citric Acid cycle where it is utilized to produce ATP via oxidative phosphorylation, and 
alternatively, into the de novo lipogenesis pathway to be converted into fatty acids22 .  These 
fatty acids can further be processed into to triglycerides necessary for fat storage, and further 
elongated, and saturated/desaturated for use in cell membranes and signaling molecules.  In 
times of starvation, Acetyl-CoA, coupled to oxaloacetate, can be converted back into glucose via 
gluconeogenesis pathway and beta oxidation can be used to provide energy via fat storage in the 
form of ketone bodies(Figure 2)22. 
These essential functions of the liver in regulating metabolic homeostasis are controlled 
and regulated by multiple hormones, transcription factors, and nutritional signals22.  Two such 
factors are Sterol Regulatory Element Binding Protein 1 (SREBF1) and Nuclear Receptor 4A1 
(NR4A1).  SREBF1 is a transcription factor, embedded inside the endoplasmic reticulum 
membrane23 .  SREBF1c, the predominant isoform in the liver, is responsible for regulation of 
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genes involved in de novo lipogenesis such as Fatty Acid Synthase (FASN), Acetyl-Coa- 




Figure 2.  Liver Metabolism at a Glance. Overview of Liver Metabolic Pathways indicating 
genes in this study that were significantly altered in the knockout mice and knockdown cells 
lines. 
 
FASN, for example, is a multifunctional protein that is the second step in de novo lipogenesis, 
which synthesizes palmitate from acetyl-CoA and malonyl-CoA24.  NR4A1, an orphan nuclear 
receptor,  also plays roles in lipid metabolism regulation.  When overexpressed, this protein has 
been shown to decrease the expression of SREBF1c, mitochondrial glycerol-3-phosphate 
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acyltransferase (GPAT2), FASN, and the low density lipoprotein receptor (LDLR)25.  GPAT2, for 
example, converts diacylglycerol into a triacylglycerol; whereas, the converse is observed upon 
NR4A1 deletion25.  Dysregulation of many enzymes and proteins involved in transport, 
synthesis, degradation, and storage, have implications for disease.  Lipid transport around hepatic 
cells involves fatty acid binding proteins (FABPs).  The liver specific isoform, FABP1, plays a 
critical role in maintaining the homeostasis of this organ.  FABP1 binds long chain fatty acids 
and other molecules and functions as a cellular taxi26 .  It is involved in intercellular storage and 
transport of fatty acids and their acyl-CoA building blocks, promoting utilization of long-chain 
fatty acids, and plays a cytotoxic role in binding to excess of fatty acids and other disruptive 
molecules27,28.  Decreases of this gene can lead to steatosis concomitant with decreased 
expression of beta oxidation genes, coupled with increased fatty acid uptake and expression of 
lipid droplet genes29,30.  Other important lipid transport proteins are involved in lipoprotein 
secretion.  Very-low-density-lipoproteins are vesicles formed of lipids and protein that a cell uses 
to remove excess fatty acids31.  Apolipoprotein C-III (APOC3) and Apolipoprotein B (APOB) 
dysregulation can lead to failure to form very-low-density-lipoprotein (VLDL), which can lead 
to an accumulation of lipid species within the cell31 .   Increased expression of genes such as 
glycerol-3-phoshphate acyltransferase (AGPAT9) and DGAT2 can lead to an increase in 
triglyceride formation, as these genes are directly involved in triglyceride formation.  The 
gluconeogenic enzymes G6PC and PCK1 can also be implicated in hepatic disease. Decreased 
expression of these enzymes could theoretically lead to a higher concentration of acetyl-CoA; 
therefore, allowing more of it to pass over to fatty acid synthesis.  An excess of lipids leads to an 
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increase in lipid storage genes and contributes to increases in cellular stress genes such as 
Perilipin 1 and 2 (PLIN1,2) and Uncoupling Protein 2 (UCP2), respectively.  PLIN1 is an 
enzyme that coats the outside of lipid droplets and regulates their degradation and utilization in 
adipocytes, but shows increased expression in NAFLD, while PLIN2 has a similar function in 
the liver.  Expression of UCP2 is controlled by fatty acid levels and monitors mitochondrial 
membrane potential which is  an indicator of stress, and as fatty acids accumulate, it is cytotoxic 
to the cells, thereby causing stress to the cells32.  With potential increases in lipid molecules, 
increases in lipid signaling via sphingosine kinase 1 and 2 (SPHK1; SPHK2) could  
possibly increase.  These kinases generate a bioactive molecule, sphingosine-1-phosphate, which 
can modulate cell survival , inflammation, and migration, from the precursors of serine and 
palmitoyl-CoA33,34.  Therefore, dysregulation in any of these pathways has the potential to lead 
to hepatic disease states such a NAFLD and NASH.    
NAFLD 
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming an epidemic in the world, 
with 25% of the population being affected35 .  Due to the incidence of this disease increasing 
over the last twenty years, NAFLD has become second most common cause for liver transplant 
for patients in the United States36 .  NAFLD is a result of dysregulation of lipid homeostasis in 
hepatocytes which leads to the accumulation of lipids (steatosis) within the cytosol of the 
hepatocyte37 .  In some patients, simple steatosis is nonmalignant, while in others it can further 
progress to nonalcoholic steatohepatitis, which is characterized by hepatocyte ballooning, 
inflammation, and fibrosis37 .  NASH can further progress to cirrhosis, liver failure, and 
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hepatocellular carcinoma, increasing the need for liver transplants38 .  The liver is the critical hub 
for lipid homeostasis, involved in generation of new lipid species, export of lipids acquired from 
the diet to other tissues in the body, and the acquisition of energy from catabolism39 .  These 
processes maintain homeostasis through a plethora of interactions among various transcription 
factors, hormones, and nuclear receptors38 .  The accumulation of lipid within the liver is directly 
caused from dysregulation of these processes.  Although there is a large body of knowledge 
about molecular pathways controlling these processes, the molecular players that regulate this 
homeostasis are still not completely understood.   
Mllt3 whole body knockout mice display characteristics of liver disease 
 Previously in the laboratory, conditional whole body Mllt3 knockout mice were generated 
which displayed characteristics of liver disease, namely, NAFLD (CSH and NZL, unpublished 
data).  These mice displayed increased weight and increased in liver size compared to their non-
knockout counterparts (Figure 3A).  In addition to this, the mice also had increased white 
adipose tissue that was present with concomitant increases in cholesterol  in the plasma and 
triglycerides in the liver (Figure 3B and C).  In addition to these features, liver slices stained with 
Oil Red O, a lipophilic dye, revealed an increase in lipid accumulation in the Mllt3 whole body 
knockout mice as compared to their non-knockout control mice (Figure 3D).  Importantly, these 
lipid droplets were more numerous and larger compared to those in controls.  To determine a 
potential liver-intrinsic regulatory function of Mllt3, our lab generated liver specific knockout 
mice. They were engineered by crossing the Mllt3flox/flox mice with mice that express Cre 
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recombinase regulated by the albumin promoter (Alb-Cre), in which Mllt3 deletion will only 
occur within hepatocytes where albumin in normally expressed.  
 
A        B     














Figure 3.  Whole Body Mllt3 Knockout Mice Display Fatty Liver Phenotype.  Previous Data 
from Zeleznik-Le lab indicating in (A), increases of mouse weight compared to controls, in (B), 
increases in white adipose tissue, in (C), increases in cholesterol and triglycerides, and (D), Oil 

























Purification of Plasmid DNAs to be Used For Lentivirus Production  
 Several plasmid DNAs were used for this research project.  Knockdown MLLT3 
lentivirus plasmid LLXm3sh1 (referred hereafter as shMLLT3; glycerol stock #1073) and the 
control CSIem empty lentiviral vector (referred hereafter as VC; glycerol stock # 1069) were 
both gifts from Dr. Tariq Enver (University of Oxford, UK)40  . Both of these also express GFP 
from the same vector so infected cells will also express GFP. The lentivirus packaging plasmid, 
pCMV-dR8.2 (glycerol stock #1333), and the envelope protein plasmid, pCMV-VSVG (glycerol 
stock #1334) were both gifts from Dr. Jiwang Zhang (Loyola University Chicago).  These 
plasmids were first aseptically quadrant streaked from glycerol stocks in the -80°C onto plates 
containing 10mL LB agar  containing 20uL ampicillin (Research Products International 
Corporation, Cat#: 69-52-3; 50mg/mL) and incubated overnight at 37°C in order to isolate 
bacterial colonies used for expansion in liquid media.  The following day, isolates were picked 
aseptically and added to 200mL of fresh LB (Fischer Bioreagents: BP1426-2; 25g/L), previously 
autoclaved, containing 400uL of ampicillin (50mg/mL) and placed in a shaking incubator at 
250rpm for 12-16 hours at 37°C.  The following day, the DNA was extracted using the Plasmid 
MIDI Prep 100 Kit (Qiagen: Cat# 12145).  Briefly, the bacteria were spun down at 6,000 x g for 





Buffer P2 was added and the cells were vigorously shaken for 15 seconds and allowed to lyse for 
5 minutes at room temperature.  Following the lysing, 4mL of Buffer P3 was added to cease the 
lysing through incubation on ice for 15 minutes.  Following that incubation, the cells were then 
centrifuged at >20,000 x g for 30 minutes at 4°C.  Next the supernatant was filtered through 
gauze into a 50mL falcon tube to facilitated removing further cellular debris.  A filter tube 
supplied by the Qiagen kit was equilibrated using 5mL of QBT buffer and letting it pass through 
the filter by gravity flow.  The supernatant in the 50mL falcon tube was then applied to the filter 
tube and allowed to flow through by gravity flow.  The DNA was now contained within the 
filter.  The DNA was then washed by applying 10mL of QC wash Buffer.  The DNA was then 
eluted into a suitable 15mL plasmid screw cap tube with a round base (Sarstedt, 
Cat#:60.540.500), by applying 5mL of the elution QF Buffer  to the filter tube.  Once the DNA 
was eluted, it was precipitated from the solution using .7x 100% isopropanol (3.5mL).  This tube 
was then inverted up and down a few times and centrifuged at >12,000 x g for 30 minutes at 4°C.  
A pellet formed on the side of the tube and the supernatant was decanted and the pellet was 
washed with 70% ethanol, flicked in order to dislodge the pellet and centrifuged again at 
>12,000 x g for 10 minutes at 4°C.  Following centrifugation, the supernatant was again 
decanted, and the pellet was allowed to dry for 5-7 minutes at room temperature.  Finally, the 
pellet was resuspended in 300uL of TE (10mM Tris, 1mM EDTA, pH 8.0) and stored at 4°C. for 
subsequent experiments.   
Transfection of DNA Plasmids Into HEK293T Cells for Lentivirus Production 
 In order to generate cell lines in which MLLT3 would be stably knocked down as well as 





that will express short hairpin RNAs to knockdown MLLT3 will be packaged into lentivirus 
particles. Lentivirus particles will be used to infect target cells.  HEK293T cells were utilized as 
packaging cells for lentivirus production.  These cells were cultured in DMEM media 
(Dulbecco’s Modification of Eagle’s Medium with 4.5g/mL glucose and L-glutamine without 
sodium pyruvate, Corning Cellgro, Cat #10-017-Cl) with Fetal Bovine Serum (Foundation BTM 
Fetal Bovine Serum; FBS; Gemini Bioproducts Cat#: 900-208) and 1% Penicillin-Streptomycin 
(100x, Corning, Cat#30-002-Cl) at 37°C and 5% CO2.  HEK293T cells (2 x 106) were seeded 
into 10cm2 plates (Olympus Plastic Tissue Culture Plate, Tissue Culture Dish, Cat#:25-202) 16-
24 hours before the transfection commenced.  The following day, three to four hours before the 
transfection, the media was removed and 10mL of fresh DMEM + 10% FBS and 1% P/S media 
was added.  Using the CalPhos Mammalian Transfection Kit (Clontech; Cat# 631312), the 
following reactions were set up: 10ug of plasmid DNA, 6.5 ug of pCMV-dR8.2 (1333), 3.5ug 
pCMV-VSVG (1334), 87uL of 2M Ca+, 700uL 2x HBS, and nuclease free water up to a total 
volume of 1.4mL.  In a 1.5mL Eppendorf tube, the water, plasmids, and 2M Ca+ was combined 
and mixed.  The 700uL of 2x HBS was aliquoted into a 5mL snap top conical.  The 2x HBS was 
then vigorously vortexed as the H2O/plasmid/Ca+ mixture was added dropwise to the 5mL tube.  
The resultant mixture was then incubated for 20 minutes in the hood to allow Calcium/Phosphate 
complexes to form.  Following incubation, the tubes were then gently mixed and 1.4mL of the 
DNA/CaPO4 complexes were added dropwise to each dish.  The plate was then rocked back and 
forth gently to ensure full distribution of the DNA/CaPO4 complexes throughout the plate.  The 
plates were then incubated overnight at 37°C and 5% CO2.  The following day, the media was 





10% FBS and 1% P/S was added, and the cells were placed back into the incubator overnight.  
The following day, the media was harvested and stored in a falcon tube and stored at 4°C.  5mL 
of fresh DMEM was added to the plates and they were incubated overnight.  The next day, the 
final media was harvested and combined with media of the same construct from the previous 
day.  The falcon tubes containing virus media were then centrifuged  at 500 x g for 5 minutes to 
remove cellular debris.  The virus was then aliquoted in 1.5mL volumes into screw cap tubes 
with an O-ring.  The virus was subsequently snap frozen on dry ice and placed into -80°C until 
used for experiments. 
Transduction of Virus into Hepatocellular Carcinoma Cell Lines 
 The human hepatocellular carcinoma cell lines HepG2 (HB-8065) and Huh7 (both kindly 
provided by Dr. W. Qiu, Loyola University Chicago) were utilized for transduction 
experiments41.  Cells were thawed from liquid nitrogen and placed in to a 37°C bath for 1-2 
minutes and immediately placed into a 15mL falcon tube containing 5-6 mL of DMEM 
containing 10% FBS and 1% P/S.  The cells were then centrifuged at 1250rpm (~500 x g) for 5 
minutes at 22-25C.  Following centrifugation, the supernatant was decanted, and the cell pellet 
was homogenously resuspended in 10mL of fresh DMEM contain 10% FBS and 1% P/S which 
was plated onto a 10cm2 plate and placed into a 37°C incubator with 5% CO2.  On the first day 
of the transduction, HepG2 cells were seeded at a density of 4.5 x 105 cells per well into a six 
well plate (Olympus Plastics Tissue Culture Plate, 6 well Flat/bottom, Cat#:25-105) and allowed 
to attach to the plate, with separate plates being used for the vector control and the shMLLT3 
knockdown.  HuH7 were prepared in a similar fashion, except 1 x 105 cells were seeded.  The 





subsequently thawed in a 25°C bath.  Aliquots of virus containing the same construct were 
combined into the same falcon tube.  Polybrene (4mg/mL; 500x stock; Sigma, Hexadimethrine 
bromide Cat#: H9268), was added to the virus for a final concentration of 8ug/mL which is 
equivalent to 2uL of Polybrene per 1 mL of virus and mixed well.  The media in each well of the 
six well plate was subsequently removed and 1.5mL of virus + Polybrene was added to each 
well.  The cells were then centrifuged for 2 hours at 2,225rpm (1000 x g; Beckman GS-6KR 
Centrifuge, Indianapolis, IN), at 33-35°C.  After the spin, the virus was either removed and 1mL 
of fresh DMEM containing 10% FBS and 1% P/S was added, or the virus was left on and 1.5mL 
of fresh DMEM containing 10% FBS and 1% P/S was added to the well for a final volume of 
3mL in each well.  The cells were then placed into a 37°C incubator with 5% CO2 overnight.  
The following day, the cells were continued to be cultured or split if necessary.  The next day the 
cells were prepared for sorting via flow cytometry.  Virus-infected cells can be sorted because 
the lentiviral vectors also co-express GFP. Briefly, the media was removed from each well and 
the wells were washed with 2-3mL of 1x PBS.  The 1x PBS was then aspirated and 500uL of 
.05% trypsin (.25%Trypsin/2.21mM EDTA 1x [-] sodium bicarbonate Stock, Corning, Cat# 25-
053-Cl) was added to each well and the cells were allowed to detach for 5-7 minutes in a 37°C 
incubator.  Following successful detachment of the cells from the plate, 2.0 mL of DMEM was 
added to dilute the trypsin and the cells were pelleted in a centrifuge at 1250rpm for 5 minutes at 
22-25°C.  Following centrifugation, the media was decanted, and the cell pellet was resuspended 
in 1mL of DMEM and filtered through a filter (Crosstex International 3½” x 5 ¼” (9 x 13 cm) 
Filter Ref#: SCXS ) into a  5mL polystyrene round-bottom FACS tube (Corning, Cat#:352054) 





22-25°C.  The supernatant was then removed and the cells were resuspended in 300-500uL of 
DMEM prior to flow cytometry.  The cells were then sorted using fluorescence activated cell 
sorting (FACSAria, Becton Dickinson, San Jose, CA) by their expression of GFP.  GFP positive 
cells from each construct were sorted into separate collection tubes. After sorting, cells were 
seeded at different cell densities in order to perform subsequent experiments.   
     Oil Red O Staining  
 Oil Red O is a lipophilic dye which allows positive staining of neutral lipids while 
excluding the cell membrane.  An Oil O Red stock solution was first prepared by adding Oil Red 
O (Sigma: O-0625) to 100% isopropanol at a concentration of 5g/mL and allowed to dissolve 
completely overnight.  Aliquots of this stock solution were used to prepare working solutions for 
experimentation.  16-24 hours before staining, 2 x 105 HepG2 cells were seeded into wells on a 
24 well plates (specifics) and DMEM containing 10% FBS and 1% P/S was added to a final 
volume of 2mL.  HuH7 cells prepared in a similar fashion, except the number of cells seeded 
was dependent upon the amount of cells I was able to sort.  The amount seeded varied between 1 
x 104 to 1 x 105.  The plates were placed into the 37°C incubator overnight and the cells were 
allowed to attach.  DPBS containing Ca2+ and Mg2+ was prepared by .10g/L of CaCl2, .10g/L of 
MgCl2•6H2O, .20g/L KCl, .20g/L KH2PO4, 8g/L NaCl, and 2.16g/L of Na2HPO4•7H2O.  The 
pH was adjusted to 7.3 using a digital pH meter (Accumet Basic AB15 pH Meter Cat#:13-636-
AB15) by adding HCL.  To begin the experiment, the media was removed from wells containing 
the cells and the cells were subsequently washed twice with 1-2mL DPBS + Ca2+ and Mg2+, at 
pH7.3, to fully remove DMEM.  The DPBS was then removed and 4% formaldehyde solution 





to a final concentration of 4%) was added to the cells and the solution was allowed to incubate at 
room temperate in the dark for 30 minutes. During this incubation period, an Oil Red O working 
solution was prepared.  This was done by adding 3 parts of the Oil Red O Stock solution to 2 
parts of distilled H2O (3:2 ratio, isopropanol concentration final of 60%)  The solution was then 
mixed well and allowed to incubate for 15 minutes at room temperature.  After the incubation 
period, the Oil Red O working solution was filtered through a Whatman #3 (Sigma-, Cat# 
10013-090) filter into a clean receptacle and was used within 2 hours.  Following fixation by 
formaldehyde, the 4% formalin solution was removed from the wells and the cells were washed 
with dH2O twice.  To facilitate uptake of the dye solution, 500uL of 60% isopropanol was added 
to each well and allowed to incubate for 5 minutes at room temperature.  The isopropanol was 
then removed and 500uL of the working Oil Red O solution was then added to each well.  The 
cells were then incubated in the Oil Red O solution for 30 minutes at room temperature.  After 
the incubation, the Oil Red O solution was removed and the cells were subsequently washed 3-
5x with dH2O to remove background staining.  500uL of dH2O was then added to the cells so the 
staining would not dry out and were stored at 4°C until photography and quantification.  Cells 
were then photographed using a microscope (EVOS xL Core Cat# AMEX1000).   
RNA Extraction and Purification 
 To obtain RNA from both the vector control and knockdown cell lines, the media was 
removed from the cells and the cells were washed with 5mL of 1x PBS.  The PBS was removed 
and 1mL of Tri Reagent (Sigma; Cat#T9424)was added.  For mouse liver tissue, approximately 
100mg tissue frozen at -80°C was placed in dry ice and 1mL Tri Reagent added directly to the 





fragments.  RNA was extracted following the company supplied protocol.  Briefly, 1mL of Tri 
Reagent, enough volume for up to 5 x 106 cells or 100mg tissue, was added. The cells were then 
transferred to a 1.5mL Eppendorf tube and processed immediately or stored at -20°C until 
extraction.  Prior to extraction, the tubes were allowed to thaw at room temperature, and vortexed 
to mix up the solution. Chloroform (Sigma, Cat# C2432; 0.2mL per 1mL of Tri Reagent) was 
added to the tubes. The tubes were then shaken vigorously for 15 seconds then allowed to 
incubate at room temperature for 2-15 minutes.  The duration of incubation time depended upon 
the amount of cells being used for the extraction.  Following the incubation period, the cells were 
then centrifuged at 12,000 x g for 15 minutes at 4°C.  Following the spin, the solution was 
separated into three distinct layers.  A bottom layer containing protein, a middle layer containing 
DNA, and a top aqueous layer containing RNA.  The top aqueous layer was pipetted into a new 
1.5mL Eppendorf, and both the protein and DNA layer was stored at 4°C to be utilized later.  To 
precipitate the RNA, 0.5mL of 100% isopropanol (Fisher Biosciences Cat# BP2618-4), per 1mL 
of Tri Reagent used, was added to the tube and mixed well.  The tube was allowed to incubate at 
room temperature for 5-10 minutes.  To pellet the precipitated RNA, the tube was then 
centrifuged at 12,000 x g for 10 minutes at 4°C.  After the RNA was pelleted, the supernatant 
was removed and the cell pellet subsequently underwent two sequential washes.  The first wash 
consisted of adding 1mL of 75% ethanol (Decon Laboratories Incorporated, Cat#64-17S) to the 
pellet and vortexing the tube to loosen the pellet.  The tube was then centrifuged at 7,500 x g for 
5 minutes at 4°C.  Following the centrifugation, the supernatant was again removed, and the 
RNA pellet was washed with 70% ethanol and vortexed to loosen the pellet.  The tube was again 





room temperature.  For both HepG2 and HuH7 cell RNA, the pellet was resuspended in 30uL of 
nuclease free water and for the mouse liver RNA, the RNA pellet was larger and needed an 
increased volume to fully dissolve the RNA pellet that ranged from 100uL to 250uL.  RNA was 
quantified using a Nanodrop (Thermo Scientific, Nanodrop 2000C Spectrophotometer, 
Cat#ND2000). The RNA was then snap frozen on dry ice and stored in the -80°C freezer and 
utilized for subsequent experiments.   
cDNA Generation 
 In order to perform gene expression analysis via quantitative PCR, RNA extracted from 
cell lines and mouse liver tissue, was converted to cDNA using the High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems; Cat #4368813).  The following PCR reaction 
was set up: 2.00uL of 10x RT Buffer, 0.80uL of 25x dNTP Mix (100mM Stock Solution), 
2.00uL of 10x RT Primers, 4.20uL Nuclease free water, 2ug of RNA, and 1uL of Reverse 
Transcriptase (50U/µL).  The kit components consist of 10uL of the total 20uL reaction.  The 
other 10uL came from the RNA that was aliquoted in a tube at a concentration of 2ug and 
brought up to a final volume of 10uL with nuclease free water.  The 20uL reactions were placed 
into 100uL (MidSci, Pryme PCR Ergonomic Tubes, Cat#B77201) PCR tubes and placed into a 
thermocycler (Applied Biosystems Veriti 96 Well Fast Thermal Cycler, Cat#:4375786).  The 
following cycling conditions were used to maximize the efficiency and output of the reaction: 
one cycle at 25°C for 10 minutes, one cycle at 37°C for 2 hours, and one cycle at 85°C for 5 
minutes and a hold at 4°C.  The samples were then removed from the thermocycler and stored in 






Quantitative PCR Analysis 
 qPCR was performed on cDNA extracted from vector control and MLLT3 knockdown 
cells from HepG2 and HuH7 cells a well as from control and Mllt3 knockout liver tissue.  The 
TaqMan Fast Advanced Master Mix (Applied Biosystems; Cat # 4444556) was used for these 
experiments and the following qPCR reaction was set up: 10uL of 2x TaqManÒ Fast Advanced 
Master Mix, 1uL 20x Gene Primer/Probe (All Probe: .5uM Stock; All Primers: 1uM , 1uL 20x 
housekeeping gene primer/probe, 1uL of cDNA, and 7uL of dH2O.  Reactions were set up into 
individual master mixes and subsequently added to reaction tubes containing necessary volumes 
for a triplicate reaction.  The cDNA was then added to these tubes in volumes necessary for 
triplicate reactions.  These tubes were then aliquoted in 20uL volumes into a 96 fast well 
(MidSci qPCR Plates 96 x.1mL Cat#: AVT3890) plate in triplicate.  Following placement of 
protect film over plate (MidSci Thermal Seal,Cat# TS-Rt2RR-100) , the plate was loaded into a 
Quantstudio 6 Flex machine (Applied Biosystem).  On the software (Quantstudio Real-Time 
Software) the following experimental properties were set up: quantstudio6, fast 96 well, 
comparative Ct, taqman reagents, and a fast 96 well.  Target genes were labeled and the correct 
fluorophore Was chosen.  The samples were correctly added to the sample name list, and the 
wells were assigned with the correct samples and gene name that was setup before the reaction 
was set up.   In some cases, a specific gene reaction was duplexed with a housekeeping gene 
(different color probe fluorescence) that acted as a normalizing control.  The following cycling 
conditions were set up: a hold stage at 50°C for 2 minutes, a hold stage at 95°C for 20 seconds, 
and 40 cycles of the PCR stage at 95°C for 1 second and 60°C for 20 seconds.  Comparative Ct 





independent reaction).  DDCt values were calculated by comparisons between the experimental 
sample Ct and the control sample Ct.    
RNA Sequencing 
 To gain genome-wide information regarding MLLT3-dependent gene expression, RNA 
sequencing analysis was performed on HepG2 cells with MLLT3 knockdown (and vector 
control) at both 48 hours and 72 hours post transduction.  The RNA was extracted from the cells 
following the protocol described above.  Once the RNA was obtained, it was further processed 
and RNA Integrity Number (RIN) determined prior to sending the samples for RNA-seq.  The 
RIN is a method to determine the integrity of the RNA and is determined by using the ratio of 
the 28s to 18s rRNA, as measured by a bioanalyzer.  To further clean the RNA from possible 
DNA contaminants, the Turbo DNA-free Kit (Ambion Cat#: AM1907) was used to remove 
DNA contamination.  RNA was aliquoted into a fresh tube at a concentration of 2ug in 50mL of 
nuclease free water.  To remove contaminating DNA, 0.1x the total volume (5uL in this case) of 
the DNAse buffer and 1uL of DNAse enzyme was added to the sample tube and mixed well.  
The tubes were then placed into a 37°C bath and incubated for 30 minutes.  Following the 
incubation, the tubes were removed from the bath and 5uL of DNAse inactivating reagent , 
which binds DNase and divalent cations, which can then be pelleted, was added to the tubes.  
The tube was incubated for 5 minutes and during this time the tube was flicked 2-3 times to 
redistribute the inactivating reagent.  Following this incubation period, the tubes were 
centrifuged at 12,000 x g for 1.5 minutes, allowing the DNAse inactivating reagent to pellet on 
the side of the tube.  After the supernatant was carefully pipetted into a fresh tube and 





Agilent RNA 6000 Nano Reagents Kit (Agilent Cat# 5067-1511).  The protocol that was 
provided by the company was followed to ensure proper analysis.  First, the reagents on the kit 
were removed from the 4°C, and were allowed to equilibrate for 30 minutes to room temperature 
but kept in the dark.  Next, 500uL of RNA 6000 Nan Gel Matrix was aliquoted into a Snap Filter 
Tube (Agilent Cat#5185-5990) and centrifuged at 500 x g for 10 minutes.  Following 
centrifugation, 65uL of that filtered gel was aliquoted to a fresh .5mL tube provide by the 
company (Aglient, Safe-Lock Eppendorf Tubes PCR Clean for gel-dye mix).  Next, the RNA 
6000 Nano Dye Concentrate was vigorously vortexed for 10 seconds and then briefly spun 
down.  1uL of the dye was then aliquoted to the .5mL tube containing the 65uL of filtered gel. 
 
Table 1: qPCR Primers Used For Mice Gene Expression Analysis 








musculus GGT CCT TCG AAT CCG CAT C 
Polr2a Probe 
Mus 




























































































































/56-FAM/ACG CTG GCT /ZEN/TCA TCT TGC CAA TTG 
/3IABkFQ/ 
 
Table 2: qPCR Primers Used For Human Gene Expression Analysis 




























































sapiens TGG GCA TGA AGC GGG AA 
RXRA Probe 
Homo 



















































sapiens CTC GCT GCC TAC TGG AG 
FASN Probe 
Homo 














































The tube containing the dye and the gel was then vortexed well to ensure proper mixing and 
centrifuged at 13,000 x g for 10 minutes at room temperature.  Once this was finished the tube 
was kept in the dark and used within the day.  Following this, a tube containing the RNA 6000 
NanoLadder, was thawed from the -80°C and the RNA nanochip was set up.  Initially, the 
Bioanalyzer needed to be cleaned.  So 350uL of RNAse Zap (ThermoFisher Scientific 
Cat#:AM9780) was added to a nanochip labeled “RNAse Zap” and placed into the bioanalyzer 
for 1 minute.  To wash that off, 350uL of nuclease free water was added to a different nanochip 
and placed into the bioanalyzer for 10 seconds and then removed.  The lid on the bioanalyzer 
was kept open to ensure that the water would evaporate before the sample nanochip was added.  
Briefly, the nanochip was set up by placing it into the chip priming station and adding 9uL of 
spin filter gel and dye to the well on the chip labeled by G that was surrounded by a circle.  
Following addition of the 9uL,  a syringe was used to put pressure onto that well.  The syringe 
was ensured to be above or at 1mL, the syringe applied to the well and pushed all the way into 
the well for 30 seconds exactly.  Immediately at 30 seconds, the pressure of the syringe was 
released and 5 seconds was allowed to pass.  After the five seconds, the syringe was placed back 
to 1mL and removed from the well.  After this, two more wells labeled “G” had 9uL of the spin 
filter gel added to them.  Following this, 5uL of the RNA Nano Maker was added to the wells 
labeled 1-12 and the well labeled with a ladder.  Next, 1uL of the ladder added to the well 
labeled ladder.  Next 1uL of sample was added to each of the sample wells.  If there were not 
enough samples to fill all sample wells, 1uL more of the RNA Nano Marker was added to each 





mixer and allowed to vortex the solutions around the chip for 1 minute at 2400 rpm.  Finally, the 
nanochip had to be used within 5 minutes of this and was placed into the bioanalyzer and 
analyzed using the company provided software.   
Albumin-Cre Mice 
The Mllt3flox/flox mice in our lab were crossed with mice that express Cre recombinase only in the 
liver (B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/J), also called Albumin-Cre (Alb-Cre) mice. Mice that are 
Mllt3flox/flox; Alb-Cre will delete Mllt3 only in liver cells. The control mice used were age and 
sex-matched and possessed a Mllt3flox/flox genotype.  Genotypes were determined by extraction of 
DNA from the tails with subsequent PCR using specific primers (Table 2) which would indicate 
the presence or absence of the Mllt3 alleles.  After the mice were sacrificed, the liver was 
dissected out and split up for subsequent experiments.  A liver chunk was embedded in paraffin 
which was sent to a pathologist for hematoxylin and eosin staining which would enable 
observation of any Mllt3del effect on the cells.  Another section was frozen in freezing material 
and saved at -80°C for subsequent cryosectioning after which the liver samples are stained with 
Oil Red O solution and hematoxylin in order to determine lipid accumulation.  Finally, sections 
of liver were stored for subsequent RNA extraction and gene expression analysis. 
Cell Culture 
  All cell lines were cultured in DMEM containing 10% Fetal Bovine Serum and 1%P/S 
and cultured on 10cm2 dishes.  As cells got confluent the media was removed and the cells 
washed with 5mL 1x PBS.  The PBS was removed and 2mL of .05% trypsin was added and the 
cells were placed into a 37°C incubator to detach for 5-7 minutes.  6 mL of DMEM (containing 





pipetted into a falcon tube and centrifuged at 1250rpm for 5 minutes at 22-25°C.  Once the cells 
were pelleted, the media was removed and the cells were resuspended in 1mL of DMEM + 
10%FBS and 1%P/S.  HEK293T cells were split at a culturing ratio of 1:10 (100uL) and both 
HepG2 and HuH7 cells were split at a culturing ratio of 1:5 (200uL) into a fresh 10cm2 plate 
containing 10mL of fresh DMEM with 10% FBS and 1% P/S.  Cells that were utilized from this 
step that were needed for RNA or other experimentation, were counted using a hemocytometer 
first, and the cell number determined for plating for different experiments. 
 
Table 3.  Primers Used For Genotyping Alb-Cre Mice  








Musculus TGA TCT CCG GTA TTG AAA CT 
Mllt3 wt F 
Mus 
Musculus TGC TCA GAA ACA GGA CAG AGT 
Mllt3 wt R 
Mus 












To Determine Liver Intrinsic Role of MLLT3 
   Knockdown of MLLT3 in Human Hepatocellular Carcinoma Cell Lines 
As mentioned in the background, whole body Mllt3 knockout mice were generated and 
these mice displayed characteristics of obesity and hepatic steatosis.  These characteristics 
included increased total body weight, increased liver weight, increased white adipose tissue, 
increased triglycerides as determined by Oil Red O staining, and concomitant increases in 
expression of some relevant metabolic genes expression in Mllt3 whole body knockout mice as 
compared to the control littermates. These observations led us to hypothesize a liver intrinsic role 
for MLLT3 in liver metabolic homeostasis.   
To investigate the role of MLLT3 within liver cells in vitro, lentivirus particles 
containing either the vector control construct or the shMLLT3 construct were packaged utilizing 
HEK293T cells.  In addition to containing a short hairpin RNA that targets MLLT3 in the 
shMLLT3 construct, both plasmids also code for GFP.  This enables visualization of the cells 
infected by the viruses as well as determination of the efficacy of virus infection.  To determine 
transfection efficiency, the packaging HEK293T cells were visualized under an EVOS 
microscope to determine the amount fluorescence present (Figure 4A and B).  The vector control 









Figure 4.  GFP Expression in HEK293T Cells Following Transfection of Lentivirus 
Plasmids.  HEK293T cells expressing GFP as visualized through fluorescence microscopy 72 
hours after transfection with plasmids for lentivirus particle production.    (A) cells expressing 
the shMLLT3 construct, and (B) cells expressing the VC construct. Bar indicates 400um. 
 
Successful transduction of lentivirus particles containing the vector control and the shMLLT3 
knockdown constructs respectively, into the human hepatocellular carcinoma cell line, HepG2, 
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was confirmed by fluorescence microscopy. To obtain purified cell cultures with all cells 
expressing the vector control or the shMLLT3 construct, 48 hours after transduction these cells 
were sorted using fluorescence activated cell sorting (FACS).  In order to determine the 
transduced cells from the untransduced cells, non-infected HepG2 cells were initially utilized to 
set the sorting gates to control for any cell autofluorescence.  Based on the autofluorescence 
signal, conservative gating was set; cells displaying greater than a 103 GFP (FITC) signal were 
selected for sorting and subsequently collected.  This enabled the collection of only GFP+ cells 
that express the constructs of interest, both the shMLLT3 and the csiem, respectively (Figure 
5A).  As I observed in the packaging 293T cells (above), the vector control transfected HepG2 
cells had a more dim GFP signal than the MLLT3 knockdown cells (Figure 5B). Interestingly, 
following MLLT3 knockdown, HepG2 cells started to display morphological characteristics that 
were different compared to the vector control cells.  These included weaker adherence, a more 
raised appearance, slower initial proliferation, and slower adherence to the plate (Figure 5B).  To 
confirm knockdown of MLLT3 in the sorted GFP+ HepG2 cells, quantitative reverse-
transcriptase PCR (qRT-PCR) was performed.  RNA extracted from different times following 
transduction (72 hours and 1 to 5 weeks), was converted to cDNA and subjected to qRT-PCR.  
Expression of b-2 microglobulin (B2M) was used to normalize MLLT3 expression.  I confirmed 
that MLLT3 expression was decreased to approximately 20% of the levels observed in VC 
HepG2 cells (Figure 6). Decreased MLLT3 expression was maintained throughout the time 


















Figure 5.  Flow Cytometry Plots Indicating Gating Strategy For Sorting GFP+ Cells and 
Morphological Differences Displayed by shMLLT3 Cells.   (A) Flow cytometry plots 
indicating the gating utilized to sort for pure populations of GFP expressing cells.  (B) Phase 
contrast and fluorescence microscopy images of the VC HepG2 cells (top) and shMLLT3 HepG2 




Figure 6. qRT-PCR to Determine MLLT3 Knockdown Efficiency in Transduced, Sorted 
HepG2 Cells.  RNA isolated from transduced, sorted HepG2 cells was converted to cDNA and 
used for qRT-PCR. MLLT3 expression was compared to expression of B2M, and normalized to 
MLLT3 expression in VC-transduced cells. Data displays and N=1 
 
human hepatocellular carcinoma cell line, HuH7, was subjected to viral transduction to 
determine if MLLT3 knockdown produced similar results as I found for HepG2 cells.  HuH7 
cells were transduced with lentivirus containing either vector control or shMLLT3 constructs.  
HuH7 cells were transduced with lentivirus containing either vector control or shMLLT3 
constructs.  As with the HepG2 cells, 48 hours following transduction the HuH7 cells were 
subjected to sorting by FACS.  Wild type HuH7 cells were used to determine the amount of 
autofluorescence to help set the gates for sorting (Figure 7A).  HuH7 transduced cells displaying 
a GFP fluorescence of greater then 102 FITC expression were sorted and collected, giving a pure 
culture of transduced cells to propagate and study (Figure 7B).  Similar to the HepG2 MLLT3 
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knockdown cells, the HuH7 MLLT3 knockdown cells also displayed morphological 
characteristics that were similar to the HepG2 cells with MLLT3 knockdown.  These included 
weaker and slower adherence to the culture plate, raising of the cells over time, and slower initial 

















Figure 7.  Flow cytometry plots for HuH7 cells expression of shMLLT3 and control 
constructs.  (A) Flow cytometry autofluorescence plots for untransduced HuH7 cells.  (B) flow 
cytometry plots for transduced HuH7 for the VC (left) and shMLLT3 (right). Sorting gates were 




Figure 8.  MLLT3 expression levels in HuH7 cells following transduction.  qPCR data from 
HuH7 knockdown cells indicating the expression levels of MLLT3 throughout the designated 
time course. Data Displays an N=2 for both 48 and 72 hr and an N=1 for 1wk timepoints. 
 
To determine the extent of MLLT3 knockdown, RNA was extracted from cells at 48hr, 72hr, and 
1 week following transduction, converted to cDNA and subsequent qRT-PCR was performed.  I 
determined that MLLT3 was knocked down to approximately 40% of control levels and 
maintained throughout the time course of study (Figure 8).  These results confirm MLLT3 





Determine Whether Lipid Accumulates Following MLLT3 Knockdown in Human HCC 
Cell Lines 
 
To determine lipid accumulation in in vitro studies, Oil Red O (ORO) staining was 
employed to determine the extent of lipid accumulation in these cells.  Remarkably, staining 
revealed an increase of lipid droplets in the shMLLT3 HepG2 cells compared to the vector  
control cells as early as 72 hours (Figure 9).  Interestingly, these cells were grown in normal 
DMEM media, with no addition supplementation of glucose, palmitate or other lipid promoting 
factors.  Subsequent staining on cells at one week  also displayed an increase in lipid droplet 
formation within the shMLLT3 cells compared to the vector control cells (Figure 10)  It is 
important to note that the shMLLT3 HepG2 cells contained both an increase in the number of 
lipid droplets as well as an increase in the size of some lipid droplets as compared to the vector 
control cells.  The other in vitro cell line, HuH7, was also subject to Oil Red O Staining, to see if 
the phenotype was maintained across two different cell types.  Again, staining of the shMLLT3 
HuH7 cells revealed an increase in hepatic lipid droplets as quickly as 72 hours post transduction 
(Figure 11).  This steatosis phenotype was maintained for the time course of this experiment.  
Similar to the shMLLT3 HepG2 cell lines, the shMLLT3 HuH7 displayed both an increase in the 
number of lipid droplets as well as an increase in the sizes of some droplets.  These results 
suggest a possible liver intrinsic role of MLLT3 within hepatocytes in regulating lipid 
homeostasis. 
Determine Mllt3 Expression in Liver Tissue From Mice With Liver-Specific Deletion of 
Mllt3 
 
Previously in the lab, whole body Mllt3 knockout mice were generated that displayed 

















Figure 9. Oil Red O Staining in HepG2 Cells Show Increases in Lipid Accumulation at 72 
Hours Following MLLT3 Knockdown.  Two independent experiments demonstrated increased 
lipid accumulation in MLLT3 knockdown HepG2 cells (bottom in A and B) compared to the 
vector control (top in A and B), viewed at 400x magnification. Cells were stained with Oil Red 


























Figure 10. Oil Red O Staining in HepG2 Cells Display Increased Lipid Accumulation At 
One Week After MLLT3 Knockdown.  Composite images from MLLT3 knockdown HepG2 
cells one week after transduction. Cells stained with Oil Red O are shown to have increased 
























Figure 11.  Oil Red O Staining of HuH7 cells 72 hours following MLLT3 knockdown 
display increased lipid accumulation.  Composite image of Oil Red O stained, MLLT3 





These include increased liver size, weight, and hepatic steatosis.  In order to gain an 
understanding of the liver-intrinsic role of Mllt3, mice were engineered in our lab to specifically 
delete Mllt3 within hepatocytes.  This was accomplished by breeding Mllt3flox/flox mice with mice 
that express Cre recombinase under regulation of the Albumin promoter (Alb-Cre). I participated 
in genotyping mice from the breeding to determine mice with homozygous, Mllt3flox/flox, and 
Mllt3flox/flox; Alb-Cre mice. These mice were used for subsequent experimentation.   
For my experiments, I used control and knockout littermates. These include male mice 
pairs 888/900, 865/863, 898/851, and 853/847 and female mice pairs 894/896, 890/893, 927/935, 
929/895, and 868/846 (Table 4).  
In order to determine the effect of Mllt3 knockout on Mllt3 expression within the livers 
from Mllt3flox/flox; Alb-Cre mice, qRT-PCR was performed on RNA converted to cDNA.  Mllt3 
expression is displayed from four pairs of males and 4 pairs of female mice, taken at 5.3wks, 
10wks, 13wks, and 21wks.  My results indicate that Mllt3 expression was significantly decreased 
to approximately 12.7% in knockout as compared to control mice livers (Figure 12).  It is 
important to note that although this is a full knockout, it takes place in hepatocytes only, as they 
are the only cell type that express albumin.  Other cells present in the liver, such as Stellate and 
Kupffer cells, do not express albumin, and therefore, some remaining expression of Mllt3 was 
observed during qRT-PCR analysis.    
Determination of Lipid Accumulation Following Mllt3 Knockout in Mice Livers 
Frozen liver sections from the Albumin-Cre liver specific Mllt3 knockout mice and their 
wild type counterparts were sectioned and stained with Oil Red O to determine the extent and 
any differences in lipid accumulation between them.  Oil Red O staining revealed an increase in 
hepatic lipid accumulation in the livers from Albumin-Cre Mllt3 knockout mice compared to the 
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wild type mice, for all ages of mice assessed (Figures 13-15).  As observed with the human HCC 
cell lines, the lipid droplets were both increased in amount and increased in size as compared to 
the controls.  It is important to note that, depending on the liver section, there was increased lipid 
staining in certain parts while others lay barren with no staining at all.  Further investigation into  
this phenomenon is necessary.  All together these results indicate that overall, liver specific Mllt3 
knockout results in in mice that display hepatic steatosis.  This suggests a hepatocyte intrinsic 
role of Mllt3 within the liver.   
Table 4.  List of Mouse Age and Sex Matched Pairs 
 
 
Mice # Sex Cre MLLT3 
Age at Sac (in 
Wks) 
888 M +/+ flox/flox 5.3 
900 M Alb-Cre flox/flox 5.3 
865 M +/+ flox/flox 10 
863 M Alb-Cre flox/flox 10 
898 M +/+ flox/flox 13 
851 M Alb-Cre flox/flox 13 
853 M +/+ flox/flox 21 
847 M Alb-Cre flox/flox 21 
896 F +/+ flox/flox 5.3 
894 F Alb-Cre flox/flox 5.3 
890 F +/+ flox/flox 5.3 
893 F Alb-Cre flox/flox 5.3 
927 F +/+ flox/flox 10 
935 F Alb-Cre flox/flox 10 
929 F +/+ flox/flox 13 
895 F Alb-Cre flox/flox 13 
868 F +/+ flox/flox 21 









Figure 12.  Graph of Mllt3 expression in Albumin-Cre Mouse Livers vs. Control Mouse 
Livers.  Mllt3 expression in liver tissue isolated from Mllt3flox/flox, and Mllt3flox/flox; Alb-Cre mice.  
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Figure 13.  Oil Red O Staining of Albumin-Cre Mice livers at 5.3wk display an increase of 
lipids. Oil Red O Staining of Mllt3flox/flox; Alb-Cre  and control Mllt3flox/flox male mice liver 
sections.  Livers were isolated from mice at age 5.3 weeks, and the livers immediately processed 
for freezing.  Staining was performed on frozen sections.  (A) Livers from male mice at 
400x(left) and 1000x(right) magnification, and (B) livers from female mice at 400x(left) and 




















Figure 14. Oil Red O Staining of Livers From Male Mllt3flox/flox; Alb-Cre Mice Aged 10 
Weeks Reveal Increased Lipid Accumulation Compared to Controls.  Oil Red O Staining of 
Mllt3flox/flox; Alb-Cre  and control Mllt3flox/flox male mice liver sections.  Livers were isolated from 
mice at age 10 weeks, and the livers immediately processed for freezing.  Staining was 
performed on frozen sections.  Livers from male mice at 400x(left) and 1000x(right) 
magnification. Scale bars represent 50µm (left) and 20µm (right) 
 
MLLT3 Dependent Gene Expression in the Liver Cells 
Understanding the role MLLT3 plays in the regulation of lipid homeostasis is critical to 
understanding any role that MLLT3 may have in NAFLD.  Increases in lipid accumulation as 
soon as 72hrs post MLLT3 knockdown suggest that MLLT3 must play a role in regulating 
specific genes that control these processes or directly affecting the expression of genes that 















     
Figure 15. Oil Red O Staining in Female Mllt3flox/flox; Alb-Cre  and Control Mllt3flox/flox Mice 
Aged 13 Weeks Reveal Increased Lipid Accumulation Following Mllt3 Knockout.  Oil Red 
O Staining of Mllt3flox/flox; Alb-Cre  and control Mllt3flox/flox female mice liver sections.  Livers 
were isolated from mice at age 10 weeks, and the livers immediately processed for freezing.  
Staining was performed on frozen sections.  Livers from female mice at 400x(left) and 
1000x(right) magnification.  Scale bars represent 50µm (left) and 20µm (right). 
 
To begin to understand this role gene expression analysis is necessary to determine genes that are 
either upregulated or downregulated upon MLLT3 knockdown.  Therefore, RNA extracted from 
HepG2 cells 48hr and 72hr after MLLT3 knockdown were prepared for RNA-sequencing by 
Novogene Corporation, a company that performs multiple types of next-generation sequencing, 
including RNA-sequencing.  Data received back from Novogene indicated that over 1200 genes 
were differentially expressed between the 48hr knockdown cells and the vector control cells 
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(Figure 16A).  In addition, gene ontology analysis indicated that pathways that were significantly 
downregulated included triglyceride-rich plasma lipoprotein particle, very-low-density-
lipoprotein particle, and various other pathways that utilize lipid species within the cell (Figure 
16B).  Among gene ontology terms that were upregulated in the 48hour knockdown versus the 
control cells, were collagen catabolic process, multicellular organismal catabolic process, and 
multicellular organism metabolic process (Figure 16C).  These results suggest mis regulation of a 
multitude of genes at a very early time following MLLT3 knockdown that affect the utilization of 
lipid species within the cell, thereby affecting metabolic processes, while concomitantly   
increasing extracellular interactions.     
Indeed, this imbalance between lipid utilization was characterized by differential gene expression 
patterns in many metabolic pathways including triglyceride formation and storage, lipid 
transport, lipoprotein formation, glucose metabolism, and some transcription factors that regulate 
these pathways (Figure 17).  Genes significantly upregulated in the MLLT3 knockdown cells at 
48 hours within these pathways include AGPAT9 (also known as GPAT3),  an enzyme that 
performs the first step in triglyceride formation, and NR4A1, a transcription factor known to 
positively regulate lipid metabolic gene expression.  However, several genes were significantly 
downregulated, many of which are involved in lipid utilization and repression.  These genes 
include FABP1, a protein involved in binding fatty acids and lipids and transporting them 
throughout the cell; APOC3, which is involved in very-low-density lipoprotein formation among 
other things, a process which allows lipids to leave the hepatocyte; RORC, a repressor of  
circadian rhythmic expression of lipid and glucose metabolic genes; and HMGCS2, a protein 
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Figure 16. RNA-Sequencing Data Reveals Differential Gene Expression Patterns in HepG2 
Cells Following MLLT3 Knockdown at 48 hours.  (A )Venn diagram showing the number of 
differentially expressed genes comparing the HepG2 cells after 48hr MLLT3 knockdown versus 
the control cells.  (B) Differentially regulated cellular pathways as identified by gene ontology 
pathway analysis.  Pathways downregulated are on top, and pathways upregulated are shown on 




Genes involved in the glucose anabolic pathway that were significantly downregulated at 48hrs 
of MLLT3 knockdown include G6PC and PCK1, which are key enzymes involved in 
gluconeogenesis (Figure 17).  There was also a significant increase in extracellular matrix genes 
involved in fibril formation.  These include COL1A1, COL1A2, COL4A1, and COL3A1, all of 
which are responsible for fibril trimer formation and extracellular matrix stiffening (Figure 17).  
These results suggest a potential role for MLLT3 in the homeostatic regulation of lipid genes 
involved in various processes through the cell as well as extracellular matrix-related properties.  
Interestingly, certain genes differentially expressed at 48 hours following MLLT3 knockdown 
were not significantly differentially expressed at 72 hours, with the exception of  a smaller 
number of genes.  However, many genes remained significantly increased within the 72 hour 
knockdown cells.  The RNA-seq data greater than 1400 differentially regulated genes in the 72 
hour knockdown cells compared to the vector control cells (Figure 18A).  This includes hundreds 
of genes differentially regulated between the 48 hour and 72 hour knockdown cells (Figure 18B).  
Gene ontology data revealed that significantly altered pathways in the 72 hour knockdown cell 
lines include the upregulation of extracellular matrix organization and structure, collagen 
metabolic and trimer formation, and organismal metabolic process (Figure 19A).  Gene ontology 
revealed that pathways downregulated in the 72 hour knockdown cells include negative 





Figure 17. Volcano Plot Highlighting Differentially Expressed Genes That are Involved in 
Lipid and Glucose Metabolism and Fibril Formation Following MLLT3 Knockdown in 
HepG2 Cells.  Volcano plot that displays differentially expressed genes involved in lipid and 
glucose metabolism and fibril formation. I plotted this data from RNA-seq data from 48 hour 
HepG2 MLLT3 knockdown as compared to control cells. Some relevant genes with increased 
expression following MLLT3 knockdown (red) and decreased expression following MLLT3 














Figure 18.  RNA-sequencing Data From 72 hour HepG2 MLLT3 knockdown Cells Showing 
Differentially Expressed Genes as Compared to Control Cells.  (A) Venn diagram displaying 
differentially expressed genes between the 72 hour shMLLT3 HepG2 cells and the Vector 
Control. (B) Venn diagram depicting differentially expressed genes between both the 48 hour 
and the 72 hour shMLLT3 HepG2 cells and controls. The bioinformatics analyses in this figure 












Figure 19.  Gene Ontology Graphs Displaying Significantly Changed Pathways Upon 
MLLT3 Knockdown For 72 hours in HepG2 Cells.  Gene ontology plots revealing in (A) 
pathways that are significantly downregulated and in (B) pathways that are differentially 
upregulated upon MLLT3 knockdown for 72 hours in HepG2 cells as compared to control cells. 




Significantly changed genes within the 72 hour knockdown cells again involved genes involved 
in triglyceride formation, lipid storage, lipid transport, glucose metabolism, and extracellular 
matrix formation.  As in the shMLLT3 48 hour knockdown HepG2 cells, FABP1, APOC3, 
G6PC, and PCK1, continued to be significantly downregulated in the 72 hour knockdown cells.  
In addition to these genes that were significantly downregulated, APOB, a protein involved in 
many lipoprotein formation pathways, was significantly downregulated within the 72 hour 
knockdown cell lines, as well as, PLIN2, a gene involved in lipid droplet regulation.  Genes in 
the 72 hour MLLT3 knockdown cell lines that were significantly upregulated include GPAT2, an 
enzyme involved in the last step of triglyceride formation; PLIN1, a protein involved in lipid 
droplet formation; SPHK2, which is involved in signaling pathways which involve sphinogine-1-
phosphate; and the extracellular matrix collagens, COL1A1, COL1A2, COL4A1, and COL3A1 
(Figure 20). 
Validation of MLLT3-dependent genes expression by qRT-PCR 
Genes determined to be differentially expressed from RNA-seq data were further validated by 
qRT-PCR of RNA isolated from independent samples of HCC cells following in vitro MLLT3 
knockdown and control cells from 48hr, 72hr, and 1 week time points.  Two HCC cell lines, 
HepG2 and HuH7, were used for these validation experiments.  Validation of expression of 
genes suggested by the HepG2 RNA-seq data, displayed similar expression patterns in the 48hr, 
72hr, and 1wk HepG2 knockdown cell lines.  FABP1 was decreased by 30% and 45% in the 
48hr and 72hr HepG2 MLLT3 knockdown cells respectively, which is similar to the RNA-seq 
data that showed FABP1 as downregulated (Figure 21A).  Another gene, NR4A1, displayed 
similar expression pattern to the RNA-seq data, being differentially increased in expression at 
48hrs and decreased at 72hrs following MLLT3 knockdown (Figure 21A and 21B).  Finally, 
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Figure 20. Volcano Plot of Differentially Expressed Genes Involved in Lipid and Glucose 
Metabolism and Extracellular Matrix Formation in the 72 Hour MLLT3 Knockdown 
HepG2 Cells.  Volcano plot that displays differentially expressed genes involved in lipid and 
glucose metabolism and extracellular matrix formation. I plotted this data from RNA-seq data 
from 72 hour HepG2 MLLT3 knockdown as compared to control cells. Some relevant genes with 
increased expression following MLLT3 knockdown (red) and decreased expression following 
MLLT3 knockdown (green) are indicated.  
 
Interestingly, there were genes that were differentially regulated within the qPCR analyzed data 
that differ from the expression levels determined by RNA-seq.  These include the increases of 
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50% in SPHK1 at 48hrs and greater than 4 fold at1 week (Figure 21 A and C). Interestingly, 
RNA isolated at 72hrs displayed a more than 50% decrease in expression (Figure 21B).  Other 
genes not significantly differentially expressed in the RNA-seq data were FASN, UCP2, RXRA, 
LDLR, and MLLT1 (Figure 21B).  FASN and UCP2 both had close to 2 fold increase in 
expression at 48 hours, with stabilization at 72hrs, to massive 4 fold increase in FASN and 10 
fold increase in UCP2 at 1 week (Figure 21C).  Although this data is suggestive of a role for 
MLLT3 in lipid homeostasis, these data was only generated from one independent experiment.  
However, when the data is analyzed by looking at gene expression only, and not by expression at 
a specific time point, the N is increased to seven.  These data show that there is a significant 
increase in the lipid modulating genes, SPHK1, FASN, LDLR, and in the cell stress gene UCP2 
following MLLT3 knockdown (Figure 21D).  
qRT-PCR expression data from HuH7 cells were analyzed using more biological 
replicates at each time point for each gene, and included more genes analyzed.  HuH7 MLLT3 
knockdown cells at 48hrs showed a significant increase in RXRA and significant decreases in 
NR4A1, FASN, SREBF1, MLLT1, SPHK1, SPHK2, and UCP2 (Figure 22A).  FABP1 trended 
toward being increased, but did not reach statistical significance (p=.221).  In Huh7 cells with 
MLLT3 knockdown for 72hr, there were significant alterations to the expression of some genes.  
Specifically, SPHK1 and SPHK2 were significantly upregulated while the remainder of the genes 
tested remained at similar levels as the 48hr cells (Figure 22B).  Finally, in the 1wk knockdown 
Huh7 cells, FABP1 is significantly upregulated by almost 4 fold.  Additionally, RXRA and both 
SPHK1 and SPHK2 were significantly upregulated (Figure 22C).   Here, as a possible sign of 
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Figure 21. Gene Expression in HepG2 Cells With MLLT3 Knockdown as Compared to 
Control Cells at 48hr, 72hr and 1wk.  Gene expression data measured by qRT-PCR from the 
HepG2 MLLT3 knockdown cells (KD) as compared to vector control cells (VC) at (A) 48hrs, (B) 
72hrs, (C) one week, and (D) all time points combined. A, B, and C are from one experiment 
performed in triplicate. D is from 3 timepoints, each in triplicate. Paired T-Test was performed in 
(D), and * = <.05, ** = <.01, *** =  <.001, and **** = <.0001.  A,B, and C are an N=1. D is 





These data suggest that MLLT3 knockdown is somehow disrupting the normal balance of gene 
expression involved in lipid homeostasis and lipid dependent cell signaling.  Similar analysis was 
applied to expression data from HuH7 in that these genes were also looked at regardless of time 
point following MLLT3 knockdown.  This data indicates that there significant increases in lipid 
metabolism genes FABP1 and RXRA as well as the cell stress gene UCP2 (Figure 22D).  There 
was also significant decreases in MLLT3, and the lipid homeostasis genes FASN and SREBF1 
(Figure 22D).  These results suggest that MLLT3 is regulating expression of these genes thereby 
altering liver lipid homeostasis and the alterations during the various time points indicate that the 
cell is responding to these changes.   
Expression analysis of liver tissue isolated from liver specific-MLLT3-deletion Mice 
In order to complement gene expression changes determined following in vitro MLLT3 
knockdown in human HCC cell lines, qRT-PCR was also performed using RNA isolated from 
livers of liver specific Albumin-Cre Mllt3 knockout mice. Liver tissue was isolated from both 
male and female mice with Mllt3 deletion and age/sex matched controls at 5.3 weeks, 10 weeks, 
13 weeks, and 21 weeks of age (Table 4). RNA was isolated, converted to cDNA, and was 
analyzed for gene expression all of the gene targets validated in the in vitro cell lines.  When 
comparing gene expression data from only male knockout livers compared to wild type livers, 
regardless of time point, I found significant increases in Srebf1, Col1a1, Col3a1, Mllt1, Agpat9, 
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Figure 22.  HuH7 Gene Expression in MLLT3 Knockdown Cell Lines at 48hr, 72hr, and 
1wk.  qPCR data of gene expression from HuH7 cells at 48hr (A), 72hrs (B), 1 wk (C), and a 
composite of all time points (D).  (A) and (B) are two independent experiments (n=2) run in 
triplicate and (C) is one experiment ran in triplicate.  (D) is a combination of all time points 
(n=5).  A Paired T-Test was performed in (D) and the errors bars represent the SEM. * = <.05, 
** = <.01, *** =  <.001, and **** = <.0001.  (A) displays N=2 for MLLT3, FABP1, FASN, 
NR4A1, RXRA,MLLT1, SPHK1 and 2 and an N=1 for SREBF1 and UCP2.  (B) Displays an N=2 
for MLLT3,, FABP1, FASN, RXRA, and NR4A1 and an N=1 for MLLT1, SREBF1, SPHK1, 
SPHK2, and UCP2.  (C) displays an N=1 for all genes.  (D) displays N=5 for MLLT3, FABP1, 










Figure 23. qPCR Data from Mice Albumin-Cre Liver Specific Knockout.  Male (A) and 
female (B) comparisons of gene expression regardless of mice age at sacrifice. N=6 for each 
genotype.  A Paired T-Test was performed and the errors bars represent the SEM. * = <.05, ** = 
<.01, *** =  <.001, and **** = <.0001.  (A) displays an N=5 for Mllt3 and Srebf1; n=4 for 
Col1a1, Fabp1, Agpat9, Col3a1, Col1a2, Apoc3 and Mllt1; n=3 for G6pc. (B) displays an N=7 




However, this was in stark contrast when only knockout female livers were compared to control 
female livers, again disregarding age, when looking at the same genes.  In female livers with 
Mllt3 knockout, there was only a significant increase in Srebf1 expression while significant 
decreases were observed in Mllt3 and G6pc (Figure 23B). These results are suggestive of sex 
differences in Mllt3-dependent expression of metabolic genes. The phenomenon of sex 
differences in gene expression has been previously documented in liver tissue.   
When comparing the expression data as it applied to the age of the mouse, significant 
expression was observed that fluctuated as the mouse aged.  When all livers from 5.3wk male 
and female mice were compared to wild type 5.3wk livers, again there was significant increase in 
Srebf1 while significant decreases in Mllt3, and Fabp1 were observed (Figure 24A).  Comparing 
10 week knockout livers to the control 10 week livers, there was a significant increase in Agpat9 
and Fabp1, while significant decreases were observed in Mllt3 and G6pc (Figure 24B).  When 
13 week knockout livers were compared to 13 week control livers, there were not significant 
increases in any of the genes analyzed, while significant decreases in Mllt3, G6pc, and Fabp1 
were observed (Figure 24C).  Finally, when 21 week knockout mice livers were compared to the 
control counterparts there was a significant increase or decrease in every gene analyzed.  
Significant increases were observed in Srebf1, Col1a1, Mllt1, Apoc3, Fabp1, and Col3a1 while 
significant decreases in expression were observed for Mllt3, G6pc, and Agpat9 (Figure 24D).  
Finally comparing gene expression of all livers regardless of time and sex, significant increases 
in Srebf1, Col1a1, Mllt1, and Apoc3 were observed.  Significant decreased Mllt3 expression was 
observed, while the rest of the genes analyzed were not significantly altered (Figure 25).  These 







































Figure 24. qRT-PCR Expression from Aged Matched Alb-Cre Mice.  Gene Expression Data 
from 5.3 week (A), 10 week (B), 13 week (C), and 21 week(D) mice Alb-Cre KO livers as 
compared to the WT control.  N= 2 of each genotype for (A,B,C, and D). A Paired T-Test was 
performed and the errors bars represent the SEM. * = <.05, ** = <.01, *** =  <.001, and **** = 
<.0001.  (A) Displays an n=2 for Apoc3 and all rest of genes display n=3. (B) displays an N=2 
for all genes. (C) displays an N=3 for Fabp1 and Col3a1 and an N=2 for rest of genes. (D) 





Figure 25.  qPCR Expression of select genes in Alb-Cre Mice Livers Regardless of Age and Sex. 
qPCR Data from both male and female mice (N=12 of each genotype) on gene expression 
regardless of age and sex.  A Paired T-Test was performed and the errors bars represent the 
SEM. * = <.05, ** = <.01, *** =  <.001, and **** = <.0001.  This displays an N=12 for each 
genotype. 
 
Expression of certain metabolic genes differ between sexes, while the expression of these genes 
is variable at differing mouse ages.  These genes, when compared to all livers, fail to reach 
significance possibly due to the variable differential expression between male and female livers, 











My thesis research has been to determine the liver-intrinsic component of a strong phenotype 
that was observed in Mllt3 whole body knockout mice created in our lab: hepatic steatosis that 
progressed to NASH. MLLT3 is an epigenetic gene regulator that is recruited to target genes by 
its chromatin “reader” YEATS domain, and can recruit multiple different effector complexes to 
those genes. This could cause either activation or repression of MLLT3 direct target genes. Gene 
dysregulation has been shown to be a hallmark of NAFLD in the development of steatosis. Liver 
steatosis can lead to NASH, and eventually cirrhosis and hepatocellular carcinoma that require 
liver transplantation (Cite).  De novo lipogenesis genes, such as ACC1 and FASN, have been 
shown to have increased expression in the liver of patients suffering from NAFLD, mainly 
through increased activity of the transcription factor, SREBF1c42,43.  This increase in free fatty 
acids leads to increases triglyceride formation leading to increases in lipid storage, inducing 
steatosis44.  These triglycerides can be exported out of the cell via very-low-density-lipoproteins 
(VLDL) when coupled with Apolipoprotein B and Apolipoprotein C-III or catabolized via b-
oxidation. However, in NAFLD the activity of these processes are moderately downregulated or 
are simply unable to keep with the lipid supply45.  This suggests that dysregulation between lipid 






Hepatocyte-Intrinsic Role of MLLT3 to Protect From Lipid Accumulation in Liver 
MLLT3 was knocked down in HepG2 and HuH7 by lentiviral transduction.  Generation of the 
virus took place in HEK293T cells and since the constructs possessed GFP, I was able to 
determine the viral efficiency in these cells (Figure 4).  Upon transduction into the in vitro cell 
lines, GFP positive cells were sorted using flow cytometry which established potentially pure 
colonies of MLLT3 knockdown and control cells to study(Figure 5A and Figure 7).  MLLT3 
knockdown efficiency was confirmed by qPCR for both cell lines (Figures 6 and 8). Upon 
MLLT3 knockdown, both cell lines, HepG2, and HuH7, displayed increases in lipid 
accumulation, as visualized through Oil Red O staining, compared to the vector control (Figures 
9-11).  The knockdown cells also displayed weaker adherence, slower proliferation, and a more 
rounded up appearance (Figure 5B).  Liver specific Albumin-Cre knockdown of Mllt3 was also 
confirmed by qPCR and the phenotype mimics the steatosis seen in whole body Mllt3 knockout 
mice (Figure 12 and Figures 13-15).  Both the in vitro and in vivo data suggest that there is a 
hepatocyte-specific role for MLLT3 in maintaining liver lipid homeostasis through apparent 
regulation of genes functioning in many metabolic pathways.  The functionality of MLLT3 is 
seemingly conserved between mouse and human cells, and further study needs to be given to this 
protein so that potential therapeutic options may be uncovered.   
Mllt33 Regulated In vivo Gene Expression 
In my research I set out to determine gene expression alterations causing the observed phenotype 
in MLLT3 knockdown hepatocyte cell lines and in liver tissue from liver specific Mllt3 knockout 
mice.  As mentioned above, some specific gene alterations are known to occur in patients with 




that MLLT3 may play a role in regulating gene expression in some of these pathways.  
Interestingly, removal of MLLT3/Mllt3 produced gene alterations across a multitude of processes 
involved in liver metabolism.  These include gluconeogenesis, de novo lipogenesis, triglyceride 
synthesis, lipid storage and lipid removal.  In liver specific Mllt3 Albumin-Cre knockout mice 
livers, Srebf1 expression was significantly increased (Figure 23, 24A,C,and D, and 25).  Srebf1 
codes for the Srebf1c protein, which is known to directly activate genes involved in de novo 
lipogenesis. My data suggests that upon Mllt3 knockout, dysregulation of this critical 
transcription factor occurs causing alterations in genes involved in this process, thereby 
increasing the cellular concentrations of free fatty acids (FFAs) within the hepatocytes.  My data 
suggests a role by MLLT3 in maintaining proper levels of the SREBF1 transcription factor.  
Interestingly, SREBF1 was found to be a direct target gene of MLLT3 in the HeLa cell line6 , 
and was confirmed as a direct Mllt3 target gene in liver tissue from our whole body Mllt3 
knockout mice (NJA, CSH, NZL, unpublished).  As mentioned before, FFAs have a number of 
fates within the liver, and one is to be shuttled into the triglyceride forming pathway.  Coupled 
with the increases in Srebf1, significant increases in Agpat9, were observed in all male Mllt3 
knockout mice as well as in 5.3wk and 10week age matched mice (Figure 23A and Figures 24A 
and B).  This suggests that increases in concentrations of FFAs within the hepatocyte led to an 
increase expression of enzymes necessary for triglyceride formation, which in turn led to the 
increase in lipid droplets as compared to the control mice.  Interestingly, when female mice were 
compared for expression of Agpat9, there was no significant differences between the control and 
Mllt3 knockout livers, suggesting that there may be sex-dependent differences involved in 




fatty acids to b-oxidation and ketone body formation, while males tend to shuttle free fatty acids 
to triglyceride formation and VLDL secretion46.  More investigation into this subject is necessary 
to fully determine the extent of these differences with regard to Mllt3 function.  Despite the sex-
specific differences in Agpat9 expression, some similarities between sexes were also observed.  
When looking at gene expression for a protein involved in VLDL formation and secretion, 
Apoc3, there were not differences in expression in both male and females, when compared 
regardless of age (Figure 23).  This suggests and supports research others have shown that VLDL 
secretion is relatively unaltered in patients with NAFLD45.  However, when observing gene 
expression from animals at varying ages, there was significant increase of Apoc3 in Mllt3 
knockout mice at 21 weeks of age, concomitant with increases in Fabp1 (Figure 24D). This 
suggests an accumulation of FFAs and potential removal of triglyceride particles at the later 
timepoint following Mllt3 deletion.   
The gluconeogenic enzyme glucose-6-phosphatase converts glucose-6-phosphate to 
glucose in order for the liver to release glucose into the circulation upon fasting47 .  Severe 
deficiency in the expression of G6PC, the catalytic subunit of glucose-6-phophatase, leads to 
Glycogen Storage Disease Type Ia (GSD1a), which is characterized by hepatic steatosis48. 
Without this enzymatic reaction, glucose-6-phosphate (G6P) accumulates within the cells, which 
leads to alterations in liver metabolism49. These alterations include an increase in de novo 
lipogenesis and triglyceride synthesis and elongation50.  Interestingly, I saw significant decreases 
in this gene in both male and female Mllt3 knockout livers (Figure 23).  Further, there appeared 
to be a time dependent decrease when analyzing the age matched mice (Figure 24).  Expression 




attenuation by 13 week mice, at which point that level was relatively maintained by 21 weeks.  
This low expression suggests, that Mllt3 binding at this gene normally induces its expression to 
help the liver release glucose into the circulation.  It also suggests that G6P may be accumulating 
within the hepatocytes of the Alb-Cre KO mice which could therefore be inducing fatty acid 
formation leading to increases in triglyceride storage and steatosis.  Despite some of the Mllt3-
dependent gene alterations being consistently observed in both male and female mice, and 
through the age matched comparisons, there were several genes that were either different 
between both males and females or had seemingly time dependent sporadic expression which 
ended up giving increased variability to the study.   As mentioned before, Agpat9 had differential 
expression between males and females, which has been observed in previous studies.  Several 
other genes showed a similar pattern.  When all male Mllt3 knockout mice were compared, 
significant increases were observed in Col1a1, Col3a1, and Mllt1, all of which had no expression 
changes within the female.  Apart from the sex differences, collagen expression in hepatocytes 
has been somewhat of a controversy.  Several studies concluded that hepatocytes normally 
display very low expression of collagen I and collagen III and that high deposition of collagen 
fibrils is due to other cells such hepatic stellate cells51,52.  However, much more recently, it was 
reported that in vitro EMT occurred in hepatocytes that started to express a-SMA and became 
myofibroblasts53,54.  Some in vivo studies have had conflicting perspectives.  One study tried to 
determine if there was any fibroblast markers in human explant livers, which ultimately 
determined there was no correlations; another study performed lineage tracing and showed that 
there was, in fact, a population of hepatocytes that underwent EMT55,56.  At any rate, my data 




knockout livers compared to the control mice (Figure 23A).  This expression differences 
fluctuated when analyzed at different mouse ages, however they were consistently upregulated 
following Mllt3 deletion (Figure 24).  Collagen I and III are the fibril forming collagens that are 
known to be very highly upregulated in fibrosis57.  These fibrils participate in cell/cell adhesion, 
migration, cell signaling and promoting proper liver functionality58,59.  It is possible that these 
increases could possibly have contributed to the increased fibrosis observed in the lab’s Mllt3 
whole body knockout mice (Ding, CSH, NZL, unpublished).  It is also possible that these 
increases in collagen expression could help explain the odd morphological features I noticed 
upon MLLT3 knockdown in in vitro cell lines.  As mentioned before, both HCC cell lines, 
HepG2 and HuH7, had a raised up cellular appearance; they started to clump together and they 
initially had weaker adherence to the cell culture plate.  It has been reported that several collagen 
genes, including COL1A1, are direct targets of MLLT3 in HeLa cells as shown by ChIP-seq, 
suggesting that these genes could potentially be directly bound and regulated by MLLT3 in liver 
cells6.  Further ChIP experimentation in our lab would need to be completed in HepG2 and 
HuH7 to fully determine whether these genes are direct MLLT3 targets.  In contrast to these 
observations from males, liver tissue from female Mllt3 KO mice showed no differences in 
expression of these collagen genes compared to the control (Figure 23B).  Again, this suggests 
sex differences in expression of these genes.  The literature presents conflicting information 
regarding gender and liver fibrosis.  Some report there are no differences among male and 
females during fibrotic development, while other groups have determined that hormonal 




 It is critical to note that all genes analyzed were significantly altered in the 21wk aged 
mice, which shows values for male and females combined (Figure 24D).  This dysregulation of 
these genes clearly suggest regulatory functionality of Mllt3 in liver metabolic processes.  The 
fluctuations within the livers during these age matched mice may be revealing something about 
the metabolic state of these mice due to Mllt3 knockout.  This data suggests that despite the cells 
in the liver attempting to achieve homeostasis within their metabolic pathways, by 21 weeks of 
age, all genes that I assessed were significantly altered (Figure 24D). This is indicative of the 
need to have Mllt3 present within these cells or permanent dysregulation will occur.  It is 
imperative for someone in our lab to further the studies with these liver-specific Mllt3 knockout 
mice.  Observations on older mice may shed more insight into a more dramatic role of Mllt3 in 
the liver long after homeostasis is lost.    These mice could potentially display more steatosis and 
a possible progression to NASH and/or carcinoma, particularly in male mice.  Mllt3 must 
somehow act as a sensor that may respond to metabolic intermediates or environmental signals at 
different times in order to either repress or activate various genes within these pathways.   
MLLT3 dependent in vitro gene expression  
The gene expression data from HepG2 and HuH7 HCC cell lines suggests something about the 
initial homeostatic imbalance that occurs upon MLLT3 knockdown.  There are plenty of genes 
that display alterations that are different between the cells with MLLT3 knockdown at 48hr, those 
at 72hr cells, and for certain genes, by one week the change seems to revert back to the 48hr 
status.  The fluctuations of SPHK1, for example, suggest an intrinsic cellular response to MLLT3 
knockdown, such that the cell was just trying to respond to abrupt, dramatic decreases in a 




in both HepG2 and HuH7 cell lines (Figure 21 and 22).  The end result of enhanced de novo 
lipogenesis is increased concentrations of palmitate, which is the molecule necessary to start 
sphingosine synthesis63.  This generates ceramide, which has been shown, at high concentrations, 
to be  positively correlated with NAFLD64.  Ceramide also positively influences NAFLD and the 
progression to NASH65.  SPHK1 then eventually generates sphingosine-1-phosphate (S1P), 
which is a signaling molecule and has been shown to have increased levels in mice fed a high fat 
diet, to increase lipid accumulation, promote inflammation, and increased hepatic pathology66,67.  
This suggests that increases in SPHK1 I observed following MLLT3 knockdown could result 
from one and/or two things.  First, in HeLa cells, it was reported by ChIP-seq that SPHK1 was a 
direct MLLT3 target gene which could potentially be what is occurring here6 . Second, increases 
in fatty acids, are inducing SPHK1 expression which in turn generates more S1P.  The signaling 
molecule S1P can then feedback and further exacerbate the metabolic disorder.  The declined 
expression, in HepG2, at 72 hours but the reclamation by one week, is suggestive of this analysis 
taking place at such early time points (Figure 21 B, C and D).  The cells seem to be trying to 
adjust to a potentially necessary regulator being no longer present while trying to survive.  
Interestingly, HuH7 cells also had a large increase in the expression of SPHK2, which had been 
shown to have protective phenotype in NAFLD in which knockout mice developed steatosis 
(Figure 22 B and C)68.  FABP1 expression is also low at both early time points following 
MLLT3 knockdown in HepG2 cells, but increased at early time points in HuH7 cells (Figures 21 
A,B,D, and Figure 22). This suggests that in HepG2 cells, there are probably more cytotoxic 
molecules, such as fatty acids, present in the cytoplasm inducing cellular stress, which can be 




knockdown in HepG2 cells (Figure 21 A and C).  The exact opposite is seen in HuH7 cells at 48 
hours following MLLT3 knockdown where FABP1 expression is high and UCP2 expression is 
low (Figure 22 A).  However, at 1 week following MLLT3 knockdown, Huh7 cells displayed 
high expression of both FABP1 and UCP2, which may suggest increased ROS generation or 
higher concentrations of cytotoxic molecules that FABP1 simply cannot keep up with (Figure 
22C).  The high expression of FASN in HepG2 following MLLT3 knockdown, could be 
supported by the high expression of Srebf1 following Mllt3 knockout in the mouse (Figure 21).  
As a direct target of SREBF1, FASN should be increased, and therefore increases of FFAs and 
triglycerides should be observed, again suggesting the role of MLLT3 in metabolic homeostasis 
and potential homeostatic determinant.  However, I found the opposite in the HuH7 cells, low 
SREBF1 coupled with low FASN expression (Figure 22).  In the future, gene expression analysis 
will needed to be performed on components of lipid export mechanisms, since lipid 
accumulation was seemingly occurring differently in the two different cell types.  This could be 
reflective of increased RXRA (Figure 22), which, with no ligand, is known to associate with 
various nuclear receptors and induce repression or target genes expression, most of which are 
metabolic genes69.  In any case, total gene expression for the two different HCC cell lines differ 
at these early timepoints following MLLT3 knockdown.  For HepG2 cells, when all the data is 
combined, I found significant increases in SPHK1, FASN, UCP2, and LDLR, while in the HuH7 
cell line, I saw significant increases in FABP1 and RXRA, along with significant decreases in 
FASN and SREBF1 expression (Figures 21D and 22D).  Differences inherent to these two 
different HCC cell lines could be the reason for these expression differences.  The HepG2 cells 




them, thereby increasing lipid accumulation, whereas the HuH7 cells have increases in the 
transporter FABP1, but decrease in FASN, which theoretically suggests that there should be less 
FFAs in the cytosol.  Regardless of these differences, the end result is the same.  These cell types 
have increased steatosis due to accumulations of triglycerides following MLLT3 knockdown.  
More gene expression analysis needs to be performed in order to deduce the mechanism.  In 
HuH7 cells it could be that although there isn’t increases in FFAs, the increases in triglycerides 
could potentially occur due to decreased expression of proteins needed to form VLDL and 
therefore remove these accumulated triglycerides.  In HepG2 cells it could be possible that the 
rapid influx of FFAs and triglycerides are happening too fast for the cell to remove them, which 
is seen in NAFLD patients45.   
Potential role of MLLT3 in liver metabolic homeostasis  
Trying to understand the potential role of MLLT3 within the liver and its regulation of metabolic 
homeostasis, it is important to think about how MLLT3 functions.  This protein is able to bind to 
chromatin via its YEATS domain to crotonylated histone tails6,7.  These post translational 
modifications mark active promoters and potential enhancers, which occur on genes that are 
actively being transcribed8.  Therefore, the presence of MLLT3 at these genes is likely due, at 
least in part, to their activation status in the cells, due to the histone modifications read by 
MLLT3.  Unfortunately I do not believe it is that simple.  For example, on the C-terminus of 
MLLT3 there is competitive binding for at least four different complexes, with two of those 
complexes being repressor complexes.  So it is entirely feasible that MLLT3 could be repressing 
the expression of these genes in some fashion.  Crotonylation hasn’t been fully characterized and 




repressed genes, but on a different histone amino acid that hasn’t been studied yet.  In addition, 
MLLT3 can bind to other modifications such as acetylation and in particular, H4K20 acetylation 
is associated with repression70.  Due to these facts, MLLT3 could be repressing these genes 
based on the metabolic environment of the cell.  As mentioned before, it has been shown that 
various modifications placed onto histone tails depend on the metabolic state of the cell9.  So 
MLLT3 could potentially function as a sensor within the cell which fluctuates between gene 
repression and gene expression based on the availability of the various acyl-CoAs that are 
present in the cell at that time.  This could be mechanism that the cell uses in order to respond to 
its metabolic state and adjust accordingly.  MLLT3 may be the protein that responds to these 
changes and helps modify the expression of target genes that need to be expressed at that time 
while repressing the ones that are no longer needed.   
 In addition to these potential functions, MLLT3 could also be binding and regulating 
genes that have potential enzymatic regulation functions.  Proteins that are kinases, 
acetyltransferase, ubiquitinases, or methyltransferases have the ability to not only transfer these 
molecules to chromatin, but can also transfer these posttranslational modifications onto other 
proteins and thus regulate their functions.  It is possible that MLLT3 could be binding to these 
types of proteins and activating or repressing their expression, so upon knockdown, there is 
differential expression of these proteins which in turn could potentially modulate the 
functionality of proteins within the metabolic pathways of the liver. 
 In conclusion, MLLT3 plays a critical function within the liver that is involved in 
metabolic homeostasis.  Upon MLLT3 knockout or knockdown, metabolic alterations occur that 




metabolic pathways including de novo lipogenesis, gluconeogenesis, triglyceride synthesis, and 
lipid export.  Future experiments needs to be performed in order to determine the exact 
mechanism behind these alterations.  ChIP experiments should be performed in vitro and in vivo 
to determine direct targets of this protein in order to better characterize the functionality of 
MLLT3.  More gene expression analysis, upon knockdown should be performed on more 
metabolic processes and regulators in order to fully understand the extent of this dysregulation.  
Metabolic tests should be run on the cells to determine if mitochondrial function is affected and 
to what extent.  Knockout mice should be aged to see if they eventually acquire fibrosis and 


















1. Iida S, Seto M, Yamamoto K, et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia 
encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene. 
1993;8(11):3085-3092. 
2. Nakamura T, Alder H, Gu Y, et al. Genes on chromosomes 4, 9, and 19 involved in 11q23 
abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl 
Acad Sci U S A. 1993;90(10):4631-4635. 
3. Li Y, Sabari BR, Panchenko T, et al. Molecular coupling of histone crotonylation and active 
transcription by AF9 YEATS domain. Mol Cell. 2016;62(2):181-193. 
4. Le Masson I, Yu DY, Jensen K, et al. Yaf9, a novel NuA4 histone acetyltransferase subunit, is 
required for the cellular response to spindle stress in yeast. Mol Cell Biol. 2003;23(17):6086-
6102. 
5. Schulze JM, Wang AY, Kobor MS. Reading chromatin: Insights from yeast into YEATS 
domain structure and function. Epigenetics. 2010;5(7):573-577. 
6. Li Y, Wen H, Xi Y, et al. AF9 YEATS domain links histone acetylation to DOT1L-mediated 
H3K79 methylation. Cell. 2014;159(3):558-571. 
7. Zhang Q, Zeng L, Zhao C, Ju Y, Konuma T, Zhou MM. Structural insights into histone 
crotonyl-lysine recognition by the AF9 YEATS domain. Structure. 2016;24(9):1606-1612. 
8. Tan M, Luo H, Lee S, et al. Identification of 67 histone marks and histone lysine crotonylation 
as a new type of histone modification. Cell. 2011;146(6):1016-1028. 
9. Sabari BR, Tang Z, Huang H, et al. Intracellular crotonyl-CoA stimulates transcription 
through p300-catalyzed histone crotonylation. Mol Cell. 2015;58(2):203-215. 
10. Bitoun E, Oliver PL, Davies KE. The mixed-lineage leukemia fusion partner AF4 stimulates 
RNA polymerase II transcriptional elongation and mediates coordinated chromatin 
remodeling. Hum Mol Genet. 2007;16(1):92-106. 
11. Smith E, Lin C, Shilatifard A. The super elongation complex (SEC) and MLL in 





12. Monroe SC, Jo SY, Sanders DS, et al. MLL-AF9 and MLL-ENL alter the dynamic 
association of transcriptional regulators with genes critical for leukemia. Exp Hematol. 
2011;39(1):5. 
13. Lin C, Garrett AS, De Kumar B, et al. Dynamic transcriptional events in embryonic stem 
cells mediated by the super elongation complex (SEC). Genes Dev. 2011;25(14):1486-1498. 
14. Peterlin BM, Price DH. Controlling the elongation phase of transcription with P-TEFb. Mol 
Cell. 2006;23(3):297-305. 
15. Zhou Q, Yik JH. The yin and yang of P-TEFb regulation: Implications for human 
immunodeficiency virus gene expression and global control of cell growth and 
differentiation. Microbiol Mol Biol Rev. 2006;70(3):646-659. 
16. Steger DJ, Lefterova MI, Ying L, et al. DOT1L/KMT4 recruitment and H3K79 methylation 
are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol. 
2008;28(8):2825-2839. 
17. Hemenway CS, de Erkenez AC, Gould GC. The polycomb protein MPc3 interacts with AF9, 
an MLL fusion partner in t(9;11)(p22;q23) acute leukemias. Oncogene. 2001;20(29):3798-
3805. 
18. Malik B, Hemenway CS. CBX8, a component of the polycomb PRC1 complex, modulates 
DOT1L-mediated gene expression through AF9/MLLT3. FEBS Lett. 2013;587(18):3038-
3044. 
19. Sanchez C, Sanchez I, Demmers JA, Rodriguez P, Strouboulis J, Vidal M. Proteomics 
analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B 
histone demethylase and the Bcl6 interacting corepressor. Mol Cell Proteomics. 
2007;6(5):820-834. 
20. Srinivasan RS, de Erkenez AC, Hemenway CS. The mixed lineage leukemia fusion partner 
AF9 binds specific isoforms of the BCL-6 corepressor. Oncogene. 2003;22(22):3395-3406. 
21. Leach BI, Kuntimaddi A, Schmidt CR, Cierpicki T, Johnson SA, Bushweller JH. Leukemia 
fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple 
partners via coupled folding and binding. Structure. 2013;21(1):176-183. 
22. Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4(1):177-197. 





24. Jones SF, Infante JR. Molecular pathways: Fatty acid synthase. Clin Cancer Res. 
2015;21(24):5434-5438. 
25. Pols TW, Ottenhoff R, Vos M, et al. Nur77 modulates hepatic lipid metabolism through 
suppression of SREBP1c activity. Biochem Biophys Res Commun. 2008;366(4):910-916. 
26. Thompson J, Winter N, Terwey D, Bratt J, Banaszak L. The crystal structure of the liver fatty 
acid-binding protein. A complex with two bound oleates. J Biol Chem. 1997;272(11):7140-
7150. 
27. Wang G, Bonkovsky HL, de Lemos A, Burczynski FJ. Recent insights into the biological 
functions of liver fatty acid binding protein 1. J Lipid Res. 2015;56(12):2238-2247. 
28. Gajda AM, Zhou YX, Agellon LB, et al. Direct comparison of mice null for liver or intestinal 
fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding. 
J Biol Chem. 2013;288(42):30330-30344. 
29. Guzman C, Benet M, Pisonero-Vaquero S, et al. The human liver fatty acid binding protein 
(FABP1) gene is activated by FOXA1 and PPARalpha; and repressed by C/EBPalpha: 
Implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim Biophys 
Acta. 2013;1831(4):803-818. 
30. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic 
steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 
2008;49(5):1068-1076. 
31. Yao Z. Human apolipoprotein C-III - a new intrahepatic protein factor promoting assembly 
and secretion of very low density lipoproteins. Cardiovasc Hematol Disord Drug Targets. 
2012;12(2):133-140. 
32. Baffy G. Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci. 
2005;10:2082-2096. 
33. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: New 
insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 2008;29(4):381-
402. 
34. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev 
Biol. 2004;15(5):513-520. 
35. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology 
of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and 




36. Pais R, Barritt AS,4th, Calmus Y, et al. NAFLD and liver transplantation: Current burden 
and expected challenges. J Hepatol. 2016;65(6):1245-1257. 
37. Loomba R, Chalasani N. The hierarchical model of NAFLD: Prognostic significance of 
histologic features in NASH. Gastroenterology. 2015;149(2):278-281. 
38. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The 
interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 
2012;56(4):952-964. 
39. Nguyen P, Leray V, Diez M, et al. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl). 
2008;92(3):272-283. 
40. Pina C, May G, Soneji S, Hong D, Enver T. MLLT3 regulates early human erythroid and 
megakaryocytic cell fate. Cell Stem Cell. 2008;2(3):264-273. 
41. Wang F, Bank T, Malnassy G, et al. Inhibition of insulin-like growth factor 1 receptor 
enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and 
survival. Hepatol Commun. 2018;2(6):732-746. 
42. Kohjima M, Higuchi N, Kato M, et al. SREBP-1c, regulated by the insulin and AMPK 
signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 
2008;21(4):507-511. 
43. Mitsuyoshi H, Yasui K, Harano Y, et al. Analysis of hepatic genes involved in the 
metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res. 
2009;39(4):366-373. 
44. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and 
insulin resistance: Lessons from genetically engineered mice. J Clin Invest. 2008;118(3):829-
838. 
45. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the 
pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23(2):201-229. 
46. Marinou K, Adiels M, Hodson L, Frayn KN, Karpe F, Fielding BA. Young women partition 
fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared 
with young men. Br J Nutr. 2011;105(6):857-865. 
47. Soty M, Gautier-Stein A, Rajas F, Mithieux G. Gut-brain glucose signaling in energy 




48. Mutel E, Abdul-Wahed A, Ramamonjisoa N, et al. Targeted deletion of liver glucose-6 
phosphatase mimics glycogen storage disease type 1a including development of multiple 
adenomas. J Hepatol. 2011;54(3):529-537. 
49. Monteillet L, Gjorgjieva M, Silva M, et al. Intracellular lipids are an independent cause of 
liver injury and chronic kidney disease in non-alcoholic fatty liver disease-like context. Mol 
Metab. 2018;16:100-115. 
50. Bandsma RH, Prinsen BH, van Der Velden Mde, S., et al. Increased de novo lipogenesis and 
delayed conversion of large VLDL into intermediate density lipoprotein particles contribute 
to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res. 2008;63(6):702-707. 
51. Herbst H, Frey A, Heinrichs O, et al. Heterogeneity of liver cells expressing procollagen 
types I and IV in vivo. Histochem Cell Biol. 1997;107(5):399-409. 
52. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization for procollagen 
types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant 
expression in nonparenchymal liver cells. Hepatology. 1989;10(1):84-92. 
53. Del Castillo G, Murillo MM, Alvarez-Barrientos A, et al. Autocrine production of TGF-beta 
confers resistance to apoptosis after an epithelial-mesenchymal transition process in 
hepatocytes: Role of EGF receptor ligands. Exp Cell Res. 2006;312(15):2860-2871. 
54. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-
beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J 
Biol Chem. 2007;282(30):22089-22101. 
55. Diaz R, Kim JW, Hui JJ, et al. Evidence for the epithelial to mesenchymal transition in 
biliary atresia fibrosis. Hum Pathol. 2008;39(1):102-115. 
56. Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis 
via epithelial to mesenchymal transition. J Biol Chem. 2007;282(32):23337-23347. 
57. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209-218. 
58. Hynes RO. The extracellular matrix: Not just pretty fibrils. Science. 2009;326(5957):1216-
1219. 
59. Flaim CJ, Chien S, Bhatia SN. An extracellular matrix microarray for probing cellular 
differentiation. Nat Methods. 2005;2(2):119-125. 
60. Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J 




61. Bambha K, Belt P, Abraham M, et al. Ethnicity and nonalcoholic fatty liver disease. 
Hepatology. 2012;55(3):769-780. 
62. Yang JD, Abdelmalek MF, Pang H, et al. Gender and menopause impact severity of fibrosis 
among patients with nonalcoholic steatohepatitis. Hepatology. 2014;59(4):1406-1414. 
63. Watt MJ, Barnett AC, Bruce CR, Schenk S, Horowitz JF, Hoy AJ. Regulation of plasma 
ceramide levels with fatty acid oversupply: Evidence that the liver detects and secretes de 
novo synthesised ceramide. Diabetologia. 2012;55(10):2741-2746. 
64. Chavez JA, Summers SA. A ceramide-centric view of insulin resistance. Cell Metab. 
2012;15(5):585-594. 
65. Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP. Role of ceramides in 
nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2012;23(8):365-371. 
66. Sanyal AJ, Pacana T. A lipidomic readout of disease progression in A diet-induced mouse 
model of nonalcoholic fatty liver disease. Trans Am Clin Climatol Assoc. 2015;126:271-288. 
67. Geng T, Sutter A, Harland MD, et al. SphK1 mediates hepatic inflammation in a mouse 
model of NASH induced by high saturated fat feeding and initiates proinflammatory 
signaling in hepatocytes. J Lipid Res. 2015;56(12):2359-2371. 
68. Nagahashi M, Takabe K, Liu R, et al. Conjugated bile acid-activated S1P receptor 2 is a key 
regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology. 2015;61(4):1216-
1226. 
69. Cave MC, Clair HB, Hardesty JE, et al. Nuclear receptors and nonalcoholic fatty liver 
disease. Biochim Biophys Acta. 2016;1859(9):1083-1099. 
70. Kaimori JY, Maehara K, Hayashi-Takanaka Y, et al. Histone H4 lysine 20 acetylation is 





















Jonathan Dixit, was born in Palos Heights, IL on February 28th, 1983 to Paresh and 
Kathleen Dixit. He attended Northern Illinois University, in DeKalb, IL where he earned a 
Bachelor’s of Science, summa cum laude, in Biological Sciences, and a minor in Chemistry, in 
May 2017. During his undergraduate research, Jonathan studied the effects of fungal reproduction, 
metabolic substrate production, and morphology in Aspergillus fumigatus, following gene deletion 
and overexpression.   
After graduation, Jonathan matriculated into the Loyola University Chicago Stritch School 
of Medicine Biochemistry and Molecular Biology Graduate Program. He completed his graduate 
studies in the laboratory of Dr. Nancy Zeleznik-Le, where he focused on investigating the role of 
MLLT3 in liver lipid homeostasis.  After completion of his graduate studies, Jonathan will pursue 



















 81  
 
 
 
 
 
